Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014218	ab-hco3-st	mmol/l (mmol/l)	18527	190290	0.00%
3014218	ab-hco3-st	— (—)	1294	2962	100.00%	Distribution not available
3014218	ab-standardibikarbonaatti	mmol/l (—)	505	904	100.00%	Distribution not available
3014218	ap-hco3st	mmol/l (mmol/l)	328	751	0.00%
3014218	ap-shco3	mmol/l (mmol/l)	141	192	0.00%
3014218	bikarbonaatti(aktuaali),valtimoveri	mmol/l (—)	117	203	100.00%	Distribution not available
3014218	ab-bikarbonaatti	mmol/l (—)	64	92	100.00%	Distribution not available
3014218	ap-shco3	— (—)	33	39	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2953

12964

2.22

321.93

9.9

8.8

24.75

24.25

mmol/l

13.32

2754

12033

Exposure to unspecified factor

3994

16147

1.99

319.96

10.3

9.5

24.29

mmol/l

0.04

3806

15001

Implicit viral Sepsis

1079

3119

3.82

319.93

13.8

7.8

24.43

24.34

mmol/l

0.30

994

2876

Viral Sepsis

1080

3125

3.81

319.73

13.8

7.8

24.43

24.34

mmol/l

0.30

995

2882

Depression medications

903

911

5.15

319.19

11.2

7.5

24.23

24.31

mmol/l

0.25

839

866

Excluding asthma or asthma-COPD overlap

3155

7218

2.26

319.06

10.7

9.0

24.53

23.88

mmol/l

21.36

2952

6840

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4587

13998

1.93

316.34

10.5

9.3

24.21

24.29

mmol/l

0.92

4384

12975

Any reimbursement code in KELA

1972

3592

2.83

316.13

11.5

8.9

24.19

24.25

mmol/l

0.34

1864

3403

Other pulmonary diagnosis

3144

7218

2.25

315.32

10.7

9.0

24.53

23.88

mmol/l

21.16

2933

6840

Type 2 diabetes, wide definition

3548

11503

2.10

314.24

10.9

8.5

24.13

24.46

mmol/l

6.15

3253

10776

Oxycodone

1731

6365

2.81

313.47

8.5

8.9

24.85

24.27

mmol/l

9.47

1607

5870

Asthma (mode)

2915

7209

2.29

313.21

9.4

9.1

24.52

23.88

mmol/l

19.74

2694

6832

Bacterial pneumonia (organism specified)

2175

8352

2.51

312.60

10.4

8.5

24.81

24.14

mmol/l

14.24

1970

7745

Viral pneumonia

773

1800

4.84

311.19

17.6

9.0

24.76

23.95

mmol/l

7.98

738

1692

COPD differential diagnosis

3129

7209

2.24

311.14

10.6

9.1

24.52

23.88

mmol/l

20.90

2925

6832

ILD differential diagnosis

3128

7209

2.24

310.78

10.6

9.1

24.52

23.88

mmol/l

20.90

2925

6832

Dentinal caries

1255

4030

3.37

309.98

15.0

9.5

23.96

24.30

mmol/l

2.81

1194

3765

Inflammatory bowel disease treatment related agents

4660

14339

1.90

309.22

9.8

9.6

24.55

24.16

mmol/l

11.88

4295

13432

Pulmonary heart disease, diseases of pulmonary circulation

1682

6395

2.84

308.96

10.6

8.5

24.60

24.30

mmol/l

2.92

1539

5911

Convulsions, not elsewhere classified

1178

3605

3.46

308.34

9.2

10.1

24.05

24.15

mmol/l

0.45

1115

3373

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5048

10467

3.22

307.65

11.3

8.9

24.74

24.07

mmol/l

30.17

4656

9883

Dental caries

1433

4557

3.38

307.65

15.0

9.5

23.92

24.29

mmol/l

3.53

1357

4257

Other respiratory disorders and diseases

1431

3934

4.15

307.65

11.2

8.4

25.94

24.15

mmol/l

55.55

1328

3603

Pneumonias (Asthma/COPD co-morbidities)

5529

13199

3.09

307.65

11.7

9.1

24.73

24.10

mmol/l

30.61

5108

12431

Other septicaemia

2042

6756

3.22

307.65

13.3

8.3

23.88

24.34

mmol/l

5.77

1899

6275

Explicit Sepsis

2363

7630

3.21

307.65

13.1

7.9

23.97

24.29

mmol/l

3.66

2193

7070

Chronic lower respiratory diseases

5022

14169

1.98

307.65

9.3

10.0

24.71

24.09

mmol/l

30.34

4621

13313

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

808

1101

6.16

307.65

11.4

9.7

24.64

24.36

mmol/l

1.18

741

1033

Other chronic obstructive pulmonary disease

2868

7645

3.46

307.65

8.4

9.1

25.17

24.08

mmol/l

45.54

2619

7125

COPD/asthma/ILD related infections

4319

10475

2.13

307.65

10.2

8.9

24.60

24.07

mmol/l

18.77

4004

9891

Cerebrovascular diseases (FINNGEN)

1803

2669

5.27

307.65

11.2

7.8

24.24

24.36

mmol/l

0.75

1725

2529

Early onset COPD

1380

4343

3.54

307.65

10.2

10.0

25.25

24.08

mmol/l

26.96

1263

4068

STROKE

2582

7513

2.51

307.65

10.9

8.7

24.31

24.47

mmol/l

1.63

2441

7081

Other heart diseases

2393

3709

4.55

307.65

15.7

8.2

24.30

24.35

mmol/l

0.27

2254

3523

Metabolic disorders

4624

12092

2.50

307.65

11.2

9.1

24.26

24.35

mmol/l

0.96

4323

11287

Tramadol

4231

9494

3.04

307.65

9.7

9.6

24.32

24.29

mmol/l

0.19

3968

8823

Asthma-related pneumonia

1974

6872

3.11

307.65

10.0

8.5

25.08

24.20

mmol/l

21.22

1801

6349

Renal failure

2801

8535

3.31

307.65

13.8

8.0

23.07

24.51

mmol/l

61.80

2606

7864

Continuous positive airway pressure

1371

2071

6.49

307.65

10.3

8.3

24.83

24.28

mmol/l

5.77

1288

1967

Heart failure and antihypertensive medication

1878

2288

6.17

307.65

15.4

8.1

24.40

24.55

mmol/l

0.85

1753

2169

Bacterial Sepsis

3026

7790

3.85

307.65

12.9

7.7

24.29

24.30

mmol/l

0.04

2775

7203

Cardiac arrhythmias

2336

5717

2.81

307.65

13.9

8.3

24.27

24.41

mmol/l

1.16

2205

5443

Opioids

4102

10000

2.23

307.65

9.6

24.26

24.25

mmol/l

0.05

3839

9305

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5298

13407

2.95

307.65

11.1

9.4

24.72

24.11

mmol/l

26.78

4877

12635

Asthma-related infections

2632

11216

2.42

307.65

9.7

9.2

24.88

24.16

mmol/l

21.43

2405

10466

Hypertension

3255

8133

2.35

307.65

12.2

9.3

24.11

24.41

mmol/l

5.38

3060

7646

Early onset COPD, excluding more controls

1380

3206

4.84

307.65

10.2

9.2

25.25

23.78

mmol/l

39.91

1263

3023

Acute renal failure

1423

3902

4.17

307.65

18.0

8.1

22.91

24.50

mmol/l

31.86

1325

3599

Disorders of lipoprotein metabolism and other lipidaemias

3793

11083

2.25

307.65

10.2

8.9

24.28

24.37

mmol/l

0.89

3537

10316

Chronic kidney disease

1722

5877

3.20

307.65

12.3

7.7

22.90

24.45

mmol/l

51.49

1602

5401

Erysipelas

2588

10229

2.44

307.65

9.7

8.7

24.44

24.34

mmol/l

0.80

2356

9524

Atrial fibrillation and flutter with reimbursement

1393

2125

4.55

307.65

14.3

8.0

24.36

24.37

mmol/l

0.01

1319

2009

Later onset COPD, excluding more controls

1379

2642

4.61

307.65

6.9

7.6

25.10

23.83

mmol/l

27.90

1272

2470

First line medication for Crohn's disease

4851

12567

2.18

307.65

9.9

9.7

24.41

24.16

mmol/l

5.33

4519

11741

Other disorders of fluid, electrolyte and acid-base balance

1649

5246

3.30

307.65

12.1

8.0

24.18

24.40

mmol/l

1.30

1537

4831

Other bacterial diseases

5341

13144

3.00

307.65

11.3

9.1

24.27

24.34

mmol/l

0.72

4931

12317

Nephropathy related operations

1063

2243

5.79

307.65

19.7

9.6

22.92

24.32

mmol/l

24.29

1010

2109

Septicaemia

2306

7513

3.20

307.65

13.0

8.4

23.96

24.33

mmol/l

4.56

2138

6966

Heart failure,strict

3450

7375

3.75

307.65

12.5

8.4

24.57

24.27

mmol/l

4.42

3189

6909

All-cause Heart Failure

3554

8747

3.21

307.65

11.9

8.3

24.57

24.25

mmol/l

5.01

3266

8153

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

4082

10278

2.46

307.65

9.5

10.3

24.28

24.38

mmol/l

1.30

3914

9434

COPD/asthma related infections

4319

10475

2.13

307.65

10.2

8.9

24.60

24.07

mmol/l

18.77

4004

9891

Malignant neoplasm, wide definition for exclusion

4082

10283

2.46

307.65

9.5

10.3

24.28

24.38

mmol/l

1.31

3914

9439

Asthma, hospital admission 2, infections

2632

11216

2.42

307.65

9.7

9.2

24.88

24.16

mmol/l

21.43

2405

10466

COPD related to multimorbidity

2491

7033

3.30

307.65

8.4

8.7

25.08

24.11

mmol/l

30.99

2259

6523

Valvular heart disease excluding rheumatic fever

2198

6329

2.69

307.65

12.4

8.2

24.36

24.22

mmol/l

1.12

2040

5926

COPD, hospital admission 2, with asthma infections

2111

5576

3.60

307.65

8.7

25.28

24.06

mmol/l

39.15

1921

5170

Respiratory insufficiency

854

1071

10.29

307.65

11.1

8.1

26.50

23.74

mmol/l

62.43

791

1011

Substance abuse, excluding more controls

2663

10024

2.45

307.65

11.4

9.9

24.29

24.21

mmol/l

0.43

2450

9436

Neoplasms

3005

6852

2.43

307.65

9.5

11.6

24.15

24.25

mmol/l

0.85

2880

6293

Heart failure and bmi 25plus

1990

4624

3.25

307.65

11.1

8.2

24.79

24.15

mmol/l

11.12

1829

4291

General symptoms and signs

4734

11147

2.20

307.65

9.6

9.7

24.28

24.25

mmol/l

0.28

4430

10439

Dialysis, with operation codes

1121

2236

6.14

307.65

19.4

9.2

22.90

24.49

mmol/l

32.21

1062

2088

Complications of medical and surgical care

3175

14628

2.15

307.65

11.5

8.8

24.28

24.33

mmol/l

0.46

3025

13555

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

4086

10278

2.46

307.65

9.5

10.3

24.28

24.39

mmol/l

1.31

3919

9434

Hard cardiovascular diseases

3553

11122

2.15

307.65

11.8

9.0

24.26

24.41

mmol/l

1.67

3314

10426

Oral corticosteroids

4553

14052

2.03

307.65

9.6

9.5

24.66

24.16

mmol/l

18.25

4184

13156

Persons encountering health services for specific procedures and health care

5148

13693

2.44

307.65

11.1

9.4

24.18

24.32

mmol/l

2.22

4883

12685

COPD, hospital admissions 1, only main diagnosis

2249

6322

3.36

307.65

8.3

8.7

25.26

24.10

mmol/l

39.38

2040

5858

Asthma, hospital admissions 3, pneumonia

1980

6887

3.11

307.65

10.0

8.5

25.08

24.20

mmol/l

20.92

1807

6363

Any event in cancer register

3897

11218

2.14

307.65

8.8

10.3

24.21

24.40

mmol/l

3.24

3730

10329

Hypertension, essential

3355

7970

2.51

307.65

11.0

9.2

24.17

24.42

mmol/l

3.82

3147

7489

Anaemias

1124

797

10.09

307.65

14.1

8.0

23.81

24.29

mmol/l

3.13

1061

758

COPD, hospital admissions 3, with asthma pneumonia sepsis

1808

4618

3.73

307.65

8.5

8.7

25.34

24.05

mmol/l

36.15

1652

4259

Other diseases of pleura

2672

8701

2.97

307.65

10.5

8.6

25.27

24.10

mmol/l

49.48

2483

8038

COPD, early/later onset

2899

8358

3.23

307.65

8.4

8.9

25.16

24.10

mmol/l

43.80

2647

7769

Codeine

3939

9885

2.27

307.65

8.7

9.6

24.25

24.26

mmol/l

0.04

3677

9196

Asthma, excluding more controls

3217

6347

2.82

307.65

9.4

8.6

24.67

23.89

mmol/l

30.97

2961

6013

Other heart diseases, wide

4034

10380

2.52

307.65

13.3

8.9

24.34

24.23

mmol/l

1.15

3780

9775

Cardiovascular diseases

2145

3804

3.18

307.65

13.0

8.4

24.10

24.18

mmol/l

0.49

2035

3619

Persons encountering health services in other circumstances, wide

5042

14122

1.91

307.65

10.4

9.3

24.28

24.29

mmol/l

0.13

4779

13072

Implicit bacterial Sepsis

2725

6944

4.04

307.65

13.2

7.6

24.26

24.29

mmol/l

0.13

2496

6412

Any gastric operation

3213

6761

2.46

307.65

11.4

8.1

24.15

24.32

mmol/l

1.84

3019

6258

Pure hypercholesterolaemia

3313

10430

2.23

307.65

9.4

8.8

24.30

24.37

mmol/l

0.67

3096

9689

Other diseases of the respiratory system

1431

3934

4.15

307.65

11.2

8.4

25.94

24.15

mmol/l

55.55

1328

3603

Heart failure, not strict

4798

10122

3.58

307.65

13.1

8.7

24.35

24.28

mmol/l

0.57

4443

9510

Heart failure, strict

3646

8890

3.24

307.65

12.2

8.3

24.56

24.24

mmol/l

5.19

3354

8288

Other chronic obstructive pulmonary disease, including avohilmo

3254

9624

3.08

307.65

8.5

9.1

25.08

24.11

mmol/l

42.81

2977

8950

GASTRO-related operations

3213

6761

2.46

307.65

11.4

8.1

24.15

24.32

mmol/l

1.84

3019

6258

Renal tubulo-interstitial diseases

4583

13332

2.80

307.65

11.7

8.7

23.72

24.48

mmol/l

33.56

4272

12426

ILD medications: prednisolone, methylprednisolone, prednisone

4855

13149

2.16

307.65

10.3

9.4

24.45

24.18

mmol/l

6.18

4494

12312

ILD medications

4850

13284

2.07

307.65

10.6

9.4

24.42

24.17

mmol/l

5.42

4484

12441

Hypertensive diseases (excluding secondary)

2207

3671

3.67

307.65

13.2

8.2

24.10

24.37

mmol/l

3.05

2085

3483

Bacterial pneumonia, not elsewhere classified

1973

6373

2.93

307.65

10.5

8.2

24.89

24.05

mmol/l

19.43

1787

5967

COPD

2982

7886

3.46

307.65

8.5

9.1

25.13

24.08

mmol/l

44.09

2725

7354

Malaise and fatigue

2485

7560

2.91

307.65

9.1

9.0

24.51

24.28

mmol/l

2.55

2288

7030

Asthma

3333

7154

2.60

307.65

9.2

9.1

24.69

23.88

mmol/l

33.65

3070

6780

Asthma (only as main-diagnosis), excluding more controls

2762

6347

2.69

307.65

9.0

8.6

24.66

23.89

mmol/l

26.31

2551

6013

Cardiovascular diseases (excluding rheumatic etc)

2555

4330

3.56

307.65

13.0

8.2

24.08

24.24

mmol/l

1.47

2423

4106

Condition for Implicit Sepsis (Organ dysfunction codes)

4701

12123

3.01

307.65

13.1

8.3

24.24

24.32

mmol/l

0.62

4385

11306

Certain infectious and parasitic diseases

4049

10130

2.06

307.65

10.6

9.0

24.25

24.28

mmol/l

0.28

3767

9525

Transplanted organ and tissue status

771

1515

6.11

307.65

24.7

10.0

23.32

24.38

mmol/l

14.48

740

1429

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2175

6711

2.70

307.65

10.1

9.3

24.06

24.47

mmol/l

7.57

2116

6088

Diseases of arteries, arterioles and capillaries

3383

11189

2.39

307.65

11.3

8.5

24.20

24.35

mmol/l

1.62

3141

10379

Provisional assignment of new diseases of uncertain etiology

2145

7924

2.88

307.65

14.8

9.0

24.60

24.17

mmol/l

7.47

2029

7416

Asthma, unspecified (mode)

2474

6552

3.16

307.65

9.0

8.9

24.76

23.89

mmol/l

28.92

2294

6198

Asthma-related pneumonia or sepsis

1980

6887

3.11

307.65

10.0

8.5

25.08

24.20

mmol/l

20.92

1807

6363

Ulcer of lower limb, not elsewhere classified

996

2611

4.44

307.65

11.8

8.8

24.26

24.29

mmol/l

0.07

935

2410

Dyspnoea

4536

14081

2.61

307.65

9.0

9.5

24.65

24.20

mmol/l

14.81

4161

13178

Abnormalities of breathing

4177

10132

2.56

307.65

9.2

9.9

24.57

24.14

mmol/l

12.01

3824

9560

Fever of other and unknown origin

2381

9162

2.52

307.65

10.7

9.4

24.16

24.26

mmol/l

0.76

2207

8559

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4507

14779

2.29

307.65

10.7

9.3

24.09

24.36

mmol/l

5.22

4201

13789

Diseases of arteries, arterioles and capillaries (FINNGEN)

1544

2066

5.80

307.65

13.2

8.2

24.16

24.34

mmol/l

1.12

1471

1954

Pain in throat and chest

3442

9891

2.20

307.65

9.0

9.8

24.35

24.15

mmol/l

2.85

3168

9329

Bleeding

3958

13464

2.25

307.65

11.2

9.0

24.25

24.34

mmol/l

0.79

3691

12538

Non-ischemic cardiomyopathy

1745

4435

3.56

307.65

11.7

8.0

24.87

24.29

mmol/l

7.98

1617

4155

Examination and observation for other reasons

2777

7400

2.38

307.65

10.4

9.8

24.26

24.37

mmol/l

1.02

2617

6958

Cerebrovascular diseases

3542

12110

2.21

307.65

9.2

9.1

24.28

24.35

mmol/l

0.56

3325

11227

Influenza and pneumonia

5623

13087

3.00

307.65

11.6

9.1

24.70

24.09

mmol/l

29.26

5191

12340

COPD, hospital admissions

2876

8315

3.23

307.65

8.3

8.9

25.16

24.11

mmol/l

44.06

2626

7725

Non-rheumatic valve diseases

2162

6290

2.66

307.65

11.8

8.2

24.38

24.23

mmol/l

1.26

2004

5889

Bacterial pneumoniae

2061

6768

2.88

307.65

10.6

8.3

24.86

24.05

mmol/l

18.59

1867

6337

COPD-related respiratory insufficiency

1090

2170

6.25

307.65

9.7

8.6

25.73

24.06

mmol/l

35.12

1001

1998

Hypertensive diseases

3264

8136

2.36

307.65

12.3

9.3

24.11

24.41

mmol/l

5.45

3066

7648

Bacterial infection, other or unspecified

3166

9241

3.37

307.65

10.9

8.3

24.35

24.33

mmol/l

0.10

2920

8588

Malignant neoplasm

3869

11162

2.14

307.65

9.5

10.1

24.32

24.38

mmol/l

0.55

3702

10286

Covid-19 confirmed case

1719

5110

3.72

307.65

16.1

8.8

24.63

24.22

mmol/l

5.39

1624

4759

5048

10467

3.22

307.65

11.3

8.9

24.74

24.07

mmol/l

30.17

4656

9883

Care involving dialysis

654

1284

6.20

307.65

15.3

10.1

22.63

24.36

mmol/l

26.99

620

1204

Codes for special purposes

2148

7935

2.88

307.65

14.8

9.0

24.60

24.17

mmol/l

7.43

2031

7427

Atrial fibrillation and flutter

1605

2567

4.38

307.65

14.8

7.9

24.31

24.38

mmol/l

0.28

1522

2430

Complications of procedures, not elsewhere classified

3473

14526

2.15

307.65

11.2

8.9

24.25

24.33

mmol/l

0.80

3289

13480

Complications of surgical and medical care, not elsewhere classified

4416

15042

2.20

307.65

11.1

9.0

24.23

24.32

mmol/l

0.97

4179

13954

Implicit Sepsis

4367

11318

3.24

307.65

13.0

8.1

24.32

24.30

mmol/l

0.09

4063

10529

COPD (mode)

2314

4093

5.10

307.65

8.7

8.8

25.21

23.87

mmol/l

50.25

2126

3858

Asthma, unspecified (mode), excluding more controls

2420

5828

3.45

307.65

9.1

8.6

24.75

23.89

mmol/l

27.80

2246

5513

Asthma (only as main-diagnosis)

2848

7154

2.49

307.65

8.9

9.1

24.69

23.88

mmol/l

29.18

2626

6780

All pneumoniae

5542

13231

3.08

307.65

11.7

9.1

24.73

24.09

mmol/l

30.69

5121

12463

Pneumonia, organism unspecified

5046

12482

3.12

307.65

10.7

9.1

24.73

24.10

mmol/l

27.50

4642

11760

Substance abuse

2663

11800

2.26

307.14

11.4

9.7

24.29

24.21

mmol/l

0.45

2450

11043

Mental and behavioural disorders due to psychoactive substance use

2720

11993

2.24

306.76

11.4

9.7

24.29

24.22

mmol/l

0.44

2506

11220

Acute tubulo-interstitial nephritis

2596

10567

2.28

301.84

9.3

8.2

24.21

24.49

mmol/l

3.57

2400

9827

Abnormal findings on diagnostic imaging of lung

2352

10233

2.38

301.28

9.8

8.7

24.85

24.24

mmol/l

15.65

2182

9467

Codeine or tramadol medication

4666

14121

1.89

299.74

8.7

9.7

24.26

24.31

mmol/l

0.47

4354

13153

Non-invasive ventilation

916

2279

4.02

298.71

10.1

7.7

25.68

24.25

mmol/l

24.86

855

2164

Lung cancer and mesothelioma

1047

2598

3.77

295.23

8.1

8.2

25.03

23.79

mmol/l

32.12

1008

2439

Benign neoplasm of colon, rectum, anus and anal canal

2319

7204

2.42

293.11

8.9

9.8

24.19

24.44

mmol/l

2.89

2147

6578

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3896

13987

1.96

291.48

13.4

8.8

24.10

24.34

mmol/l

4.36

3646

13066

Asthma (diagnoses ohter than nonallergic)

3524

15645

1.99

290.76

9.0

9.5

24.71

24.20

mmol/l

16.10

3240

14621

Adjustment and management of implanted device

1115

3547

3.50

285.75

13.0

8.4

24.20

24.37

mmol/l

0.93

1076

3231

Alcohol use disorder, Swedish definition

2575

11272

2.23

283.62

12.3

9.6

24.15

24.22

mmol/l

0.44

2380

10541

2746

11895

2.16

280.57

12.2

9.5

24.13

24.22

mmol/l

0.59

2543

11121

ILD, hospital admission 2, with pulmonary infections

654

1468

5.18

278.54

11.4

8.4

24.76

23.91

mmol/l

7.00

611

1366

Fall on same level

4568

14188

1.85

277.77

9.9

9.8

24.33

24.24

mmol/l

0.95

4280

13237

Peripheral artery disease

2210

7909

2.40

276.15

10.1

8.0

24.17

24.34

mmol/l

1.35

2026

7299

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

534

1018

6.21

275.69

5.4

9.7

24.38

24.34

mmol/l

0.11

525

932

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1503

3397

2.91

270.61

11.3

7.7

24.16

24.36

mmol/l

1.45

1402

3223

Symptoms and signs involving the circulatory and respiratory systems

3859

10169

1.95

270.13

9.7

9.9

24.31

24.14

mmol/l

2.56

3569

9597

2628

11674

2.16

269.76

12.3

9.5

24.12

24.21

mmol/l

0.60

2432

10914

Benign neoplasm: Colon

2061

6832

2.43

268.58

8.8

9.6

24.14

24.46

mmol/l

4.01

1903

6237

Other nutritional deficiencies

2526

11882

2.16

264.30

11.0

9.7

24.67

24.22

mmol/l

8.51

2340

11168

Persons encountering health services for specific procedures, not carried out

519

1003

5.99

262.44

11.1

10.3

24.03

24.32

mmol/l

1.03

489

943

Later onset COPD

1539

4672

2.82

260.90

6.6

7.8

25.07

24.05

mmol/l

22.15

1402

4285

Hypothyroidism (congenital or acquired)

716

852

4.98

260.75

11.9

7.9

24.17

24.30

mmol/l

0.45

680

810

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1367

4915

2.90

260.27

8.6

8.7

23.95

24.48

mmol/l

8.94

1329

4452

Pain in limb

3221

12076

2.00

258.49

8.8

9.8

24.37

24.28

mmol/l

0.74

3020

11287

Parasetamol

3077

7757

2.08

257.14

10.1

10.0

24.14

24.23

mmol/l

0.75

2857

7311

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2591

12749

2.12

255.03

11.9

8.6

24.30

24.33

mmol/l

0.16

2472

11807

Obesity and other hyperalimentation

2411

11465

2.17

254.09

10.8

9.6

24.69

24.23

mmol/l

8.24

2232

10776

Obesity

2402

11419

2.17

253.86

10.8

9.6

24.68

24.22

mmol/l

8.13

2223

10732

Invasive ventilation

561

1208

5.56

253.45

16.6

9.4

24.39

24.20

mmol/l

0.51

525

1131

Hypothyroidism, levothyroxine purchases

703

847

4.92

253.08

11.7

7.7

24.21

24.30

mmol/l

0.27

667

805

Hypothyroidism and >3 levothyroxin purchases

703

847

4.92

253.08

11.7

7.7

24.21

24.30

mmol/l

0.27

667

805

Benign neoplasms

2701

7301

2.15

252.98

9.1

11.4

24.15

24.26

mmol/l

1.05

2536

6710

Need for other prophylactic measures

467

863

6.68

252.06

15.8

10.4

24.28

24.30

mmol/l

0.04

447

823

Hypertensive heart and/or renal disease

1280

3523

3.02

250.92

8.8

7.8

24.21

24.46

mmol/l

1.52

1175

3265

Oedema, not elsewhere classified

1405

5361

2.77

250.89

8.8

8.9

24.51

24.27

mmol/l

1.60

1304

4984

Aplastic and other anaemias

2103

9158

2.30

250.09

9.8

8.3

23.85

24.37

mmol/l

8.37

1943

8459

ILD, hospital admissions 3, with pneumonia sepsis

573

1266

5.31

249.56

11.1

8.3

24.81

23.95

mmol/l

6.06

534

1173

L04AD Calcineurin inhibitors

680

1711

4.54

248.91

23.9

10.8

23.31

24.36

mmol/l

13.94

647

1623

Infections, IBD-co-morbidities

800

1518

4.11

247.42

11.7

9.6

24.05

24.30

mmol/l

1.18

747

1440

Atherosclerosis, excluding cerebral and coronary sclerosis

2055

7419

2.36

247.05

9.8

7.8

24.14

24.33

mmol/l

1.66

1885

6843

Pulmonary embolism

1458

5789

2.71

244.93

10.5

8.5

24.57

24.30

mmol/l

2.33

1334

5352

Venous thromboembolism

2416

11465

2.15

244.54

9.6

8.5

24.47

24.30

mmol/l

1.70

2233

10616

Haemorrhage from respiratory passages

1572

5959

2.59

242.61

10.2

9.3

24.41

24.17

mmol/l

2.04

1451

5589

Asthma/COPD (KELA code 203)

3644

14119

1.87

242.01

8.9

9.9

24.83

24.09

mmol/l

32.93

3348

13263

Antihypertensive medication - note that there are other indications

1933

4435

2.45

241.80

12.3

8.4

24.02

24.36

mmol/l

4.38

1815

4228

Brain meningioma, excluding all cancers (controls excluding all cancers)

403

676

7.31

239.64

3.8

7.5

24.12

24.49

mmol/l

1.54

396

618

Pulmonary heart disease

1458

5852

2.68

239.49

10.5

8.5

24.57

24.31

mmol/l

2.18

1334

5410

Endocrine, nutritional and metabolic diseases

2968

7583

2.04

236.91

11.9

8.7

24.06

24.33

mmol/l

4.02

2774

7151

Benign neoplasm of meninges

582

1353

4.89

235.71

5.1

8.6

24.09

24.59

mmol/l

3.33

567

1239

Benign neoplasm: Cerebral meninges

542

1198

5.18

234.14

4.9

8.8

24.04

24.63

mmol/l

3.95

528

1093

Cardiomyopathy

903

2838

3.46

233.78

15.7

8.3

24.09

24.24

mmol/l

0.55

844

2664

Other respiratory diseases principally affecting the interstitium

1018

3473

3.25

231.67

11.1

8.7

24.67

24.26

mmol/l

3.03

934

3195

Other anaemias

1941

8613

2.30

230.89

9.5

8.2

23.89

24.37

mmol/l

6.69

1793

7949

Diabetes, varying definitions

3917

13206

1.82

230.80

12.0

8.8

24.05

24.42

mmol/l

8.58

3606

12413

Medical observation and evaluation for suspected diseases and conditions

2899

7492

2.04

230.26

9.0

9.7

24.31

24.36

mmol/l

0.39

2710

7037

Paroxysmal tachycardia

844

2094

3.59

229.23

13.4

7.7

24.38

24.27

mmol/l

0.39

780

1977

Diabetes mellitus

3919

13226

1.82

229.08

11.9

8.8

24.06

24.42

mmol/l

8.02

3608

12429

Other and unspecified anaemias

1922

8547

2.30

229.05

9.5

8.2

23.88

24.37

mmol/l

6.98

1777

7887

Hypertensive Heart Disease

1145

3317

3.03

228.73

9.0

7.8

24.23

24.44

mmol/l

1.13

1051

3075

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

705

1957

4.06

224.18

8.5

8.7

23.40

24.38

mmol/l

13.88

677

1767

Other diseases of intestines

4004

13318

1.79

223.20

10.3

9.8

24.20

24.30

mmol/l

1.18

3747

12431

DVT of lower extremities and pulmonary embolism

1902

8808

2.27

221.71

9.8

8.6

24.50

24.31

mmol/l

1.70

1750

8143

Mental and behavioural disorders due to alcohol

2243

10771

2.12

220.63

11.8

9.8

24.22

24.19

mmol/l

0.10

2072

10075

ILD, hospital admissions

881

2851

3.46

220.63

10.9

8.8

24.64

24.26

mmol/l

2.44

811

2634

Insulin medication

2547

11162

2.03

219.60

12.0

8.8

23.89

24.39

mmol/l

8.39

2312

10435

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2377

12012

2.06

219.43

11.8

8.6

24.32

24.31

mmol/l

0.04

2269

11136

Other interstitial pulmonary diseases

889

2903

3.43

219.14

10.8

8.8

24.65

24.26

mmol/l

2.45

819

2686

Substance use, excluding alcohol

928

3071

3.25

219.10

9.9

10.1

24.63

24.22

mmol/l

2.95

840

2893

Viral pneumonia (unknown virus, not influenza)

463

953

5.67

218.78

23.1

10.7

24.83

24.14

mmol/l

3.93

448

909

Interstitial lung disease

889

2907

3.42

218.63

10.8

8.8

24.65

24.27

mmol/l

2.42

819

2687

Interstitial lung disease endpoints

889

2907

3.42

218.63

10.8

8.8

24.65

24.27

mmol/l

2.42

819

2687

1752

7818

2.32

218.50

9.2

9.7

24.78

24.15

mmol/l

11.92

1599

7323

Other acute lower respiratory infections

2207

10350

2.12

218.00

9.0

9.4

24.65

24.20

mmol/l

7.15

2032

9614

Unspecified privation

658

1775

4.18

217.94

10.7

9.7

24.29

24.27

mmol/l

0.06

626

1662

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2023

9722

2.18

214.74

11.9

9.9

24.23

24.21

mmol/l

0.08

1862

9090

Unspecified kidney failure

636

1708

4.26

213.18

10.5

8.1

23.20

24.52

mmol/l

10.96

586

1560

Other CVD (FINNGEN)

530

904

5.04

213.12

10.0

7.0

24.65

24.28

mmol/l

1.24

477

853

Secondary hypertension

399

738

5.91

206.10

11.9

7.8

23.23

24.23

mmol/l

6.70

383

694

Epilepsy

1393

5842

2.51

204.56

7.1

9.8

24.21

24.19

mmol/l

0.08

1329

5424

Ischaemic heart disease, wide definition

3165

10947

1.88

203.87

11.9

9.1

24.24

24.39

mmol/l

1.70

2920

10280

Type 2 diabetes

3734

12804

1.78

203.24

11.6

8.7

24.12

24.43

mmol/l

6.16

3429

12019

647

1796

3.92

202.75

13.4

9.3

24.33

24.34

mmol/l

0.04

614

1684

Acute bronchitis

1746

7930

2.26

202.61

8.1

8.8

24.74

24.23

mmol/l

7.17

1607

7324

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3666

12899

1.78

202.51

11.4

8.8

24.02

24.44

mmol/l

9.46

3348

12121

Coronary atherosclerosis

2885

10055

1.93

201.36

11.4

9.0

24.12

24.38

mmol/l

3.79

2665

9427

Valvular operations

749

2305

3.55

201.14

16.9

8.3

24.22

24.24

mmol/l

0.07

708

2162

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1192

3891

2.76

201.03

8.7

8.8

25.00

24.43

mmol/l

8.15

1146

3518

Kidney transplant status

408

818

6.06

200.93

13.6

12.5

22.60

24.45

mmol/l

22.16

393

778

Extracorporeal dialysis

464

1045

5.36

199.37

16.6

11.2

22.93

24.32

mmol/l

13.60

437

983

Other soft tissue disorders, not elsewhere classified

3517

12439

1.79

198.85

8.9

9.9

24.28

mmol/l

0.03

3286

11629

Myocardial infarction

2294

8359

2.07

198.29

11.9

8.7

24.06

24.36

mmol/l

3.95

2106

7827

Chronic periodontitis

830

2752

3.32

197.90

14.5

9.6

24.03

24.28

mmol/l

1.22

789

2571

Heart failure and coronary heart disease

1647

5527

2.38

197.69

11.5

7.7

24.25

24.38

mmol/l

0.62

1476

5118

ILD, hospital admissions 1, main diag only

787

2550

3.47

197.00

10.8

8.9

24.67

24.27

mmol/l

2.42

725

2353

Poisoning by drugs, medicaments and biological substances

999

3644

2.90

196.59

10.0

10.2

24.29

24.21

mmol/l

0.25

930

3427

Diseases of oesophagus, stomach and duodenum

4040

14664

1.72

195.49

10.5

9.3

24.25

24.32

mmol/l

0.69

3744

13700

Iron deficiency anaemia

1728

8033

2.24

195.09

10.3

8.3

24.14

24.35

mmol/l

1.58

1579

7446

Stroke, including SAH

2734

10968

1.92

194.99

9.5

8.9

24.28

24.36

mmol/l

0.62

2558

10154

Hypo-osmolality and hyponatraemia

847

2848

3.22

194.71

12.5

7.8

24.29

24.42

mmol/l

0.45

798

2621

Insulin, intermediate and long-acting

2353

12116

1.99

194.37

11.9

8.9

23.85

24.32

mmol/l

7.22

2135

11306

Ischemic heart diseases

3163

11106

1.85

194.32

11.8

9.0

24.24

24.40

mmol/l

1.85

2915

10434

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1315

2514

2.70

193.64

10.7

9.9

24.27

24.10

mmol/l

0.97

1240

2374

Symptoms and signs involving the urinary system

3080

13429

1.83

193.15

9.1

9.3

24.32

mmol/l

0.00

2857

12507

ILD medications: immunosuppressive drugs

2262

11210

2.00

192.98

13.8

9.5

24.13

24.21

mmol/l

0.61

2107

10547

Diabetes medication

3842

13811

1.73

192.91

11.3

9.0

24.07

24.41

mmol/l

7.26

3521

12967

Malignant neoplasm of brain

306

488

8.00

192.85

4.1

10.7

24.21

24.54

mmol/l

1.39

306

459

Obesity, other/unspecified

1308

5503

2.50

191.44

10.7

9.8

24.75

24.22

mmol/l

6.47

1210

5189

Alcohol use disorder, ICD-based

1833

8902

2.16

189.84

11.9

10.0

24.21

24.20

mmol/l

0.05

1688

8316

Nutritional anaemias

1995

9705

2.09

189.34

10.3

8.2

24.10

24.33

mmol/l

1.92

1828

8990

Poisoning by medicine

913

3241

2.99

189.26

10.4

24.34

24.20

mmol/l

0.57

851

3050

Obesity related asthma

1408

6168

2.41

189.04

9.1

9.5

24.97

24.18

mmol/l

15.48

1292

5800

Other and unspecified iron deficiency

1389

6056

2.42

188.48

9.9

8.2

24.18

24.32

mmol/l

0.70

1268

5605

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1015

3801

2.79

188.45

10.1

9.8

24.16

24.19

mmol/l

0.10

948

3607

Preparatory care for dialysis

367

716

6.47

188.21

11.2

11.0

22.69

24.44

mmol/l

15.92

348

675

Care involving use of rehabilitation procedures

2380

12028

1.94

185.70

11.1

9.3

24.37

24.36

mmol/l

0.08

2250

11130

Intracranial trauma

2039

7556

2.08

185.54

9.8

10.0

24.23

24.21

mmol/l

0.07

1902

7076

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

600

1702

3.96

184.79

8.4

8.9

23.42

24.38

mmol/l

11.99

578

1551

Diverticular disease of intestine

2892

10679

1.86

184.72

8.9

9.3

24.30

24.38

mmol/l

0.60

2673

9918

Brain meningioma

393

823

5.81

184.44

3.8

8.9

24.09

24.50

mmol/l

1.99

387

771

Bronchitis

3942

15704

1.69

181.78

9.3

9.4

24.56

24.22

mmol/l

8.09

3640

14674

Injuries to the head

4043

16098

1.68

181.67

9.7

9.6

24.25

24.29

mmol/l

0.29

3775

15019

Emphysema

473

1158

4.72

180.40

8.7

9.3

24.79

23.96

mmol/l

5.09

436

1075

Symptoms and signs involving cognition, perception, emotional state and behaviour

3616

15158

1.72

179.67

8.2

9.8

24.42

24.27

mmol/l

1.91

3346

14166

Diabetes, insulin treatment (Kela reimbursement)

3838

14169

1.70

179.35

11.4

9.1

24.03

24.42

mmol/l

8.62

3509

13300

Other disorders of urethra and urinary system

2544

10370

1.89

177.43

8.3

9.0

24.44

24.27

mmol/l

1.69

2369

9650

Insulin, combination of fast acting with intermediate-acting or long-acting

2547

12985

1.88

176.35

12.0

8.9

23.89

24.32

mmol/l

6.60

2312

12106

Asthma, including avohilmo

4334

15689

1.64

176.26

9.2

9.8

24.65

24.17

mmol/l

17.67

3994

14689

Benign neoplasm of meninges

582

1675

3.92

175.72

5.1

8.7

24.09

24.40

mmol/l

1.78

567

1552

Colectomy operation

879

3217

2.99

175.29

11.2

8.8

23.76

24.31

mmol/l

5.52

863

2980

Benzodiazepine use

3720

16083

1.69

174.47

8.5

9.7

24.44

24.26

mmol/l

2.50

3417

15050

Statin medication

2447

7254

1.94

173.89

12.2

9.2

24.20

24.45

mmol/l

3.31

2279

6844

Glomerular disorders in diseases classified elsewhere

672

2133

3.52

173.52

14.0

9.9

22.95

24.26

mmol/l

17.39

630

1999

Use of hypnotics and sedatives

4021

14318

1.66

171.62

9.0

9.9

24.26

24.31

mmol/l

0.41

3741

13383

Benign neoplasm: Cerebral meninges

542

1517

4.05

170.93

4.9

8.6

24.04

24.38

mmol/l

1.88

528

1411

Major coronary heart disease event

2951

11313

1.81

169.95

11.5

8.8

24.19

24.39

mmol/l

2.49

2708

10574

Glomerular diseases

915

3469

2.86

169.78

13.0

9.6

23.16

24.28

mmol/l

17.26

852

3231

Peripheral arterial reconstruction

916

3492

2.87

169.21

11.4

8.0

24.07

24.24

mmol/l

0.73

840

3189

Major coronary heart disease event excluding revascularizations

2757

10776

1.84

168.39

11.4

8.7

24.14

24.39

mmol/l

3.23

2520

10078

Stroke, excluding SAH

2534

10444

1.88

168.13

9.4

8.7

24.28

24.36

mmol/l

0.60

2363

9666

All influenza

1021

4075

2.64

167.98

9.2

9.1

24.69

24.00

mmol/l

8.42

935

3811

Presence of cardiac and vascular implants and grafts

2095

8300

2.00

167.91

12.6

8.4

24.24

24.36

mmol/l

1.00

1936

7679

Benign neoplasms

3623

12158

1.70

167.79

8.6

10.3

24.17

24.27

mmol/l

1.04

3387

11323

Any mental disorder

4201

13055

1.65

167.76

9.5

9.6

24.29

24.30

mmol/l

0.04

3874

12277

Myocardial infarction, strict

2087

7946

2.01

167.25

11.6

8.7

24.05

24.35

mmol/l

3.71

1908

7429

Hypothyroidism, drug reimbursement

393

553

5.27

166.56

11.0

8.3

24.45

24.26

mmol/l

0.50

370

520

Gout

1339

5508

2.36

166.06

10.1

9.3

23.91

24.30

mmol/l

3.24

1248

5101

Mood disorders, excluding more controls

3432

12477

1.71

165.96

9.4

9.6

24.34

24.31

mmol/l

0.18

3152

11743

Diseases of the respiratory system

2314

6045

1.97

165.88

9.6

9.1

24.44

23.90

mmol/l

11.63

2160

5730

Obesity due to excess calories

1672

8231

2.11

165.71

10.6

9.6

24.59

24.19

mmol/l

4.66

1538

7759

4150

13647

1.64

165.45

9.2

24.56

24.17

mmol/l

10.72

3832

12780

Myocardial infarction, without ST-elevation

1814

8497

2.08

165.17

10.9

8.3

24.12

24.34

mmol/l

1.87

1642

7853

Benign neoplasm of colon, rectum, anus and anal canal

2507

12721

1.85

164.51

8.7

8.9

24.18

24.37

mmol/l

2.06

2326

11810

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

776

2568

3.09

164.13

8.5

8.4

25.02

24.36

mmol/l

8.34

755

2309

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1019

3384

2.69

163.95

8.2

8.6

25.02

24.44

mmol/l

7.55

982

3052

Infections of the skin and subcutaneous tissue

2162

11612

1.92

163.52

10.9

9.9

24.21

24.25

mmol/l

0.23

2010

10888

Hernia of abdominal wall, postoperative

733

2502

3.11

163.31

10.8

8.0

24.13

24.38

mmol/l

1.15

694

2325

Psychiatric diseases

4091

12722

1.65

162.95

9.6

24.30

24.29

mmol/l

0.05

3766

11976

Diaphragmatic hernia

1519

7295

2.19

162.64

8.9

8.5

24.40

24.36

mmol/l

0.22

1418

6790

Syncope and collapse

1709

7533

2.09

160.94

9.4

9.0

24.33

24.28

mmol/l

0.28

1586

6997

Pain, not elsewhere classified

1023

4175

2.57

159.87

9.9

9.3

24.54

24.24

mmol/l

2.25

951

3914

Other diseases of urinary system

3752

12999

1.66

158.98

8.7

9.5

24.28

24.25

mmol/l

0.27

3478

12120

Artificial opening status

376

857

5.20

158.44

13.2

9.8

24.21

24.45

mmol/l

0.60

360

805

Conduction disorders

1154

4101

2.46

157.25

11.1

7.7

24.30

24.24

mmol/l

0.25

1068

3835

Diarrhoea and gastroenteritis of presumed infectious origin

2544

13210

1.80

155.92

10.5

9.2

24.18

24.27

mmol/l

0.63

2351

12335

Episodal and paroxysmal disorders

4022

12901

1.63

155.75

8.9

9.9

24.34

24.21

mmol/l

1.86

3767

12026

Asthma, hospital admissions , main diagnosis only

2957

15773

1.72

155.57

8.8

9.6

24.71

24.23

mmol/l

12.62

2723

14751

Nausea and vomiting

1088

4551

2.47

155.18

10.8

8.6

24.30

24.32

mmol/l

0.06

1004

4216

Type 2 diabetes, definitions combined

3446

12515

1.68

155.09

11.0

8.7

24.19

24.44

mmol/l

4.07

3168

11748

ILD-related respiratory insufficiency

292

556

6.82

154.88

14.0

10.1

25.30

24.39

mmol/l

2.98

271

526

Personality disorders, excluding more controls

897

3488

2.68

154.54

9.9

10.0

24.44

24.19

mmol/l

1.25

815

3313

Parodontitis or operation codes

3361

15161

1.68

154.46

10.2

9.4

24.28

24.35

mmol/l

0.67

3172

14136

Cardiodefibrillation

1661

8411

2.09

154.46

12.6

8.6

24.29

24.31

mmol/l

0.12

1539

7803

Parodontitis

3358

15159

1.68

154.38

10.1

9.4

24.28

24.35

mmol/l

0.64

3169

14134

Polyarthropathies

2608

9874

1.81

154.37

10.3

10.2

24.15

24.32

mmol/l

1.66

2427

9238

Chronic periodontitis, including avohilmo

3343

15153

1.68

153.60

10.1

9.5

24.28

24.35

mmol/l

0.67

3154

14134

L04AA Selective immunosuppressants

936

3756

2.65

153.33

17.5

9.6

23.73

24.33

mmol/l

6.60

887

3528

Cardiomyopathy (excluding other)

622

2016

3.35

153.25

18.5

8.4

24.03

24.22

mmol/l

0.64

576

1885

Gout, idiopatic and unspecified

1180

5279

2.40

153.10

10.1

9.1

23.91

24.25

mmol/l

2.32

1108

4881

Focal epilepsy

950

3847

2.63

152.63

6.9

9.8

24.18

24.25

mmol/l

0.29

914

3571

Type 2 diabetes, strict (exclude DM1)

3455

12630

1.67

151.88

11.0

8.7

24.18

24.44

mmol/l

4.08

3178

11853

Neurological diseases, wide definition

1058

2054

2.66

151.87

10.6

10.7

24.26

24.25

mmol/l

0.01

1003

1960

Viral hepatitis, IBD co-morbidity

272

473

6.29

151.77

11.9

9.3

24.30

24.24

mmol/l

0.11

253

456

Cardiac arrest

338

593

5.41

151.34

17.5

7.6

24.02

24.26

mmol/l

0.48

320

555

Cardiomyopathies, Primary/intrinsic

605

1944

3.38

151.29

18.8

8.4

24.01

24.20

mmol/l

0.62

562

1821

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

852

3304

2.77

150.36

8.7

23.87

24.46

mmol/l

6.70

831

2992

Type 2 diabetes, definitions combined, including avohilmo

3433

12469

1.67

149.37

10.9

8.8

24.19

24.44

mmol/l

4.02

3160

11712

Falls/tendency to fall

3932

12368

1.62

149.17

10.1

9.8

24.25

24.24

mmol/l

0.09

3687

11525

Diseases of liver

1410

6810

2.18

148.72

12.5

9.3

23.87

24.33

mmol/l

4.57

1318

6347

Other disorders of skin and subcutaneous tissue

2575

13744

1.77

148.66

9.4

8.9

24.33

24.34

mmol/l

0.06

2374

12789

Focal epilepsy, strict definition

892

3556

2.68

148.41

6.8

9.7

24.23

24.26

mmol/l

0.11

857

3295

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1566

6843

2.10

148.11

8.2

9.3

24.50

24.46

mmol/l

0.17

1493

6211

Calcific aortic valvular stenosis, operated

1346

6273

2.23

147.97

9.1

8.0

24.35

24.31

mmol/l

0.16

1240

5740

Calcific aortic valvular stenosis

1346

6273

2.23

147.97

9.1

8.0

24.35

24.31

mmol/l

0.16

1240

5740

Operations 2 for CAVS

1343

6267

2.23

147.14

9.1

8.0

24.35

24.31

mmol/l

0.18

1237

5734

Calcific aortic valvular stenosis, diagnosis (helper)

1343

6267

2.23

147.14

9.1

8.0

24.35

24.31

mmol/l

0.18

1237

5734

Other diseases of the digestive system

1399

6788

2.17

146.03

11.3

8.7

24.17

24.25

mmol/l

0.37

1311

6256

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

678

2363

3.05

145.61

11.2

10.4

24.17

24.22

mmol/l

0.13

634

2229

Diseases of pulp and periapical tissues

1392

6727

2.16

145.57

13.4

9.4

24.02

24.29

mmol/l

2.29

1309

6285

Calcific aortic valvular stenosis, including rheumatic fever

1345

6304

2.21

145.32

9.1

8.0

24.35

24.31

mmol/l

0.18

1238

5768

Other antidepressants

3823

12589

1.62

144.02

9.1

9.7

24.32

24.22

mmol/l

1.05

3509

11805

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

175

208

11.63

143.94

4.0

9.1

24.13

24.97

mmol/l

3.17

175

194

Vocal cord dysfunction

500

1340

3.65

143.31

12.4

7.2

24.84

24.31

mmol/l

3.44

464

1277

Intestinal infectious diseases

3321

16121

1.64

142.42

10.3

9.3

24.16

24.31

mmol/l

1.70

3078

15055

Extreme obesity with alveolar hypoventilation

301

626

5.80

142.16

10.1

10.3

26.67

24.33

mmol/l

17.91

281

594

GI-bleeding

1396

6847

2.14

141.45

11.3

8.7

24.15

24.25

mmol/l

0.48

1301

6308

Gout, FINNGEN

1339

6493

2.19

140.98

10.1

8.8

23.91

24.24

mmol/l

2.52

1248

5994

Gout, unspecified

984

4224

2.51

140.92

9.8

9.1

23.86

24.27

mmol/l

2.63

926

3906

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1015

4367

2.42

140.76

10.1

10.0

24.16

mmol/l

0.02

948

4111

Aneurysms, operations, SAH

766

2914

2.83

140.73

8.2

9.1

24.13

24.33

mmol/l

1.09

734

2700

Focal epilepsy, mode (most common among epilepsy diagnosis)

839

3341

2.68

139.92

6.8

9.6

24.23

mmol/l

0.00

809

3096

Anxiety disorders, excluding more controls

2807

11090

1.72

139.46

9.3

9.8

24.41

24.32

mmol/l

0.69

2593

10471

Suicide or other Intentional self-harm

946

3971

2.50

139.42

10.4

10.1

24.24

24.20

mmol/l

0.16

883

3734

Peripheral artery operations in Hilmo

672

2408

3.04

139.09

12.1

8.2

24.13

24.25

mmol/l

0.35

615

2202

Hernia

3398

14488

1.63

137.98

9.7

9.5

24.36

24.32

mmol/l

0.30

3142

13527

Cerebral aneurysm, nonruptured

466

1359

3.82

137.37

6.5

9.8

24.11

24.42

mmol/l

1.49

449

1270

Sleep disorders (combined)

3542

14743

1.61

136.84

9.0

9.8

24.66

24.22

mmol/l

13.28

3286

13804

Glucagon-like peptide-1 (GLP-1) analogues

2221

10424

1.82

136.71

10.1

8.7

23.98

24.43

mmol/l

6.81

2023

9720

Benign neoplasm: Colon

2108

11704

1.84

136.70

8.8

24.14

24.38

mmol/l

2.81

1947

10878

Headache

2038

9427

1.85

136.51

8.9

9.7

24.36

24.25

mmol/l

0.90

1885

8824

Chronic periodontitis, complicated

537

1725

3.49

136.39

14.6

10.4

23.93

24.27

mmol/l

1.34

516

1616

Dialysis

289

602

5.72

135.79

13.1

10.8

22.35

24.56

mmol/l

19.94

274

568

Other medical care

1557

7835

2.02

135.73

7.5

8.3

24.48

24.34

mmol/l

0.83

1487

7176

Sequelae of external causes of morbidity and mortality

1060

4758

2.36

135.05

12.2

8.8

24.30

24.32

mmol/l

0.07

1015

4433

Other (not insulin) diabetes medications

3466

13192

1.62

134.99

10.6

9.0

24.19

24.43

mmol/l

3.45

3176

12374

Diseases of the digestive system

1808

9819

1.91

133.84

11.0

8.6

24.15

24.28

mmol/l

0.89

1682

9079

Benign neoplasm of other and unspecified endocrine glands

548

1786

3.32

133.56

6.8

9.7

24.19

24.33

mmol/l

0.52

527

1644

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

599

2065

3.16

133.03

8.8

9.4

24.04

24.44

mmol/l

2.66

581

1880

Hypokalaemia

540

1755

3.34

132.54

11.9

8.2

25.05

24.44

mmol/l

2.47

505

1626

Cystitis

2926

10879

1.68

132.47

8.6

9.1

24.33

24.26

mmol/l

0.51

2708

10128

Disorders of gallbladder, biliary tract and pancreas

3584

14814

1.60

132.39

10.6

9.1

24.13

24.35

mmol/l

3.43

3359

13767

Anxiety (asthma-related co-morbidities)

1859

7935

1.89

132.36

9.5

10.2

24.37

24.27

mmol/l

0.62

1708

7517

Symptoms and signs involving the digestive system and abdomen

3738

12002

1.59

130.73

10.1

9.6

24.23

24.27

mmol/l

0.36

3485

11192

Mood [affective] disorders

3566

15074

1.59

130.64

9.5

9.7

24.31

mmol/l

0.03

3274

14148

Mood disorders

3572

15103

1.59

129.88

9.5

9.7

24.31

mmol/l

0.01

3280

14172

Insulin, fast-acting

1426

7255

2.05

129.42

12.5

9.0

23.76

24.30

mmol/l

5.85

1298

6803

Paralytic ileus and intestinal obstruction

1061

4840

2.31

129.28

11.2

8.6

24.21

24.35

mmol/l

0.61

1009

4462

Other pulmonary heart/vessel disease

322

766

4.96

128.56

14.8

10.0

24.82

24.37

mmol/l

1.28

297

715

Amiodarone users

570

1970

3.24

127.92

19.3

9.4

24.36

24.28

mmol/l

0.23

533

1835

Other arrhythmias

2015

8647

1.83

127.78

9.8

8.4

24.42

24.25

mmol/l

1.65

1864

8125

Idiopathic pulmonary fibrosis

464

1425

3.71

127.67

11.4

8.4

24.90

24.24

mmol/l

3.61

425

1313

Secondary right heart disease

300

683

5.23

126.94

14.3

9.3

24.78

24.39

mmol/l

1.01

278

637

Alcohol dependence

1173

5619

2.20

126.63

11.1

9.8

24.48

24.22

mmol/l

1.50

1076

5232

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

721

2818

2.78

126.62

13.5

10.0

23.45

24.27

mmol/l

6.18

676

2631

Intestinal stricture

1266

6271

2.12

125.01

11.4

8.6

24.09

24.36

mmol/l

1.92

1204

5791

Injuries to the hip and thigh

1805

9144

1.87

124.73

8.8

8.5

24.48

24.27

mmol/l

1.81

1694

8439

Ischaemic Stroke, excluding all haemorrhages

2270

10074

1.77

124.47

8.7

24.27

24.37

mmol/l

0.73

2106

9325

Retention of urine

1442

6270

2.04

124.16

8.2

8.9

24.26

24.23

mmol/l

0.13

1324

5786

Other anxiety disorders

1399

6292

2.03

123.95

9.7

10.0

24.37

24.18

mmol/l

1.35

1292

5964

Depression

3233

14202

1.60

123.25

9.6

9.9

24.27

24.30

mmol/l

0.17

2969

13353

Cardiomyopathy, other and unspecified

402

1146

3.87

122.20

14.2

8.2

24.12

24.24

mmol/l

0.26

377

1079

Non-allergic asthma (mode), excluding more controls

665

2490

2.76

121.25

9.9

7.9

24.97

23.84

mmol/l

15.06

601

2343

Brain glioblastoma and astrocytoma

175

258

9.29

120.38

4.0

10.7

24.13

24.58

mmol/l

1.35

175

244

Gout, strict definition

860

3736

2.49

120.15

9.7

9.3

23.83

24.26

mmol/l

2.43

804

3456

Explicit bacterial Sepsis

493

1612

3.32

119.83

11.8

8.2

24.42

24.34

mmol/l

0.17

452

1490

Direct fill therapy

595

2165

2.95

118.95

15.1

10.5

23.96

24.30

mmol/l

1.58

571

2042

Biguanides

3392

13546

1.58

118.72

10.4

9.1

24.18

24.40

mmol/l

2.93

3102

12695

Cutaneous abscess, furuncle and carbuncle

989

4538

2.28

118.66

11.5

9.8

24.32

24.24

mmol/l

0.32

917

4255

Osteopathies and chondropathies

1973

10805

1.79

118.35

9.9

8.9

24.51

24.33

mmol/l

1.38

1814

10084

Non-small cell lung cancer

776

3239

2.58

118.11

8.5

8.0

25.02

24.23

mmol/l

13.07

755

2945

Follow-up examination after treatment for conditions other than malignant neoplasms

1642

5742

1.93

118.11

8.6

9.4

24.29

24.38

mmol/l

0.54

1579

5404

Gastrointestinal diseases

1971

5476

1.84

117.06

10.9

8.7

24.15

24.34

mmol/l

1.70

1857

5141

Streptococcal septicaemia

435

1345

3.57

116.77

11.7

9.1

24.33

24.31

mmol/l

0.04

397

1259

Autoimmune diseases excluding thyroid diseases

3744

13737

1.54

116.69

10.6

9.4

24.07

24.32

mmol/l

4.41

3460

12873

Insulin, fast-acting or short human

1437

7600

1.96

116.30

12.6

9.2

23.76

24.29

mmol/l

5.70

1306

7101

AV-block

694

2473

2.69

116.25

11.8

7.2

24.19

24.22

mmol/l

0.09

642

2304

Fracture of femur

1098

4821

2.18

115.39

8.3

7.6

24.39

24.35

mmol/l

0.16

1027

4399

Aortic aneurysm

1032

4800

2.24

115.28

12.7

8.4

24.23

24.22

mmol/l

0.02

970

4436

Constipation

3132

14478

1.59

115.05

9.0

9.4

24.41

24.29

mmol/l

1.21

2886

13506

Autoimmune diseases excluding thyroid diseases, strict definition

3625

13313

1.55

114.62

10.6

9.4

24.06

24.31

mmol/l

4.21

3354

12475

Alcohol abuse, main dg, excluding more controls

628

2399

2.78

113.68

11.2

10.4

24.21

24.22

mmol/l

0.03

582

2277

Chronic periapical parodontitis

857

3780

2.39

113.61

15.7

9.3

23.94

24.30

mmol/l

2.56

808

3526

Volume depletion

444

1410

3.43

113.49

11.0

7.6

23.92

24.33

mmol/l

1.13

403

1286

Other external causes of accidental injury

2896

9047

1.63

113.15

9.9

9.6

24.27

24.25

mmol/l

0.16

2707

8406

Parodontitis and operation codes

3022

15152

1.59

113.05

10.3

9.5

24.27

24.35

mmol/l

0.74

2854

14152

Sleep apnoea

3260

14425

1.57

113.04

9.1

9.8

24.71

24.25

mmol/l

13.34

3029

13517

Amputation

519

1815

3.14

112.94

13.0

9.1

24.16

24.24

mmol/l

0.20

477

1666

Pain in joint

2039

7813

1.77

112.75

8.7

10.4

24.26

24.24

mmol/l

0.11

1931

7338

Hyperlipidaemia, other/unspecified

1475

7517

1.93

112.38

9.7

8.4

24.25

24.39

mmol/l

0.85

1354

6954

Abdominal and pelvic pain

3623

11995

1.55

112.31

10.2

9.6

24.22

24.27

mmol/l

0.47

3384

11185

All anxiety disorders

1882

8676

1.79

111.84

9.5

10.3

24.36

24.26

mmol/l

0.69

1729

8209

Unspecified haematuria

1673

7999

1.86

111.81

10.1

9.1

24.10

24.28

mmol/l

1.43

1555

7425

Problems related to lifestyle

442

1406

3.37

111.76

10.8

10.2

24.31

24.22

mmol/l

0.21

410

1328

Hyperkalaemia

315

819

4.36

110.44

10.4

7.5

23.39

24.51

mmol/l

4.15

286

753

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

283

686

4.82

110.11

7.8

9.5

23.55

24.37

mmol/l

4.24

274

636

Gingivitis and periodontal diseases

3293

11038

1.57

109.84

9.4

9.0

24.21

24.31

mmol/l

0.96

3110

10258

Other reaction to severe stress, and adjustment disorders

1125

5566

2.08

109.43

10.0

10.1

24.18

24.21

mmol/l

0.13

1046

5276

Sequelae with surgical and medical care as external cause

838

3734

2.38

109.13

12.4

8.9

24.27

24.31

mmol/l

0.13

802

3467

Other dialysis

227

467

5.92

108.97

14.4

12.5

22.52

24.44

mmol/l

13.93

213

443

Neurological diseases

2963

9450

1.61

108.68

9.5

10.1

24.21

24.15

mmol/l

0.39

2783

8851

Diseases of the skin and subcutaneous tissue

3603

11990

1.53

107.72

9.9

9.5

24.29

24.27

mmol/l

0.16

3326

11228

Personality disorders

897

4102

2.27

107.71

9.9

10.4

24.44

24.19

mmol/l

1.27

815

3885

Spondylopathies

2949

11494

1.59

107.68

7.8

9.9

24.38

24.27

mmol/l

1.12

2713

10777

Diabetic nephropathy, excluding more controls

714

2462

2.62

107.64

12.6

11.3

23.22

24.10

mmol/l

8.34

659

2280

Congenital malformations of the circulatory system

591

2181

2.80

107.12

15.4

10.6

24.31

24.21

mmol/l

0.36

576

2064

Coronary revascularization (ANGIO or CABG)

1860

7494

1.80

106.69

11.4

8.5

24.13

24.35

mmol/l

2.23

1722

7002

Abnormalities of heart beat

1149

5734

2.05

106.53

9.3

9.1

24.21

24.17

mmol/l

0.15

1061

5408

Accidents

2852

9047

1.61

104.66

9.8

9.6

24.25

mmol/l

0.00

2669

8406

Injuries to the abdomen, lower back, lumbar spine and pelvis

1416

7665

1.90

104.21

9.1

8.9

24.37

24.29

mmol/l

0.37

1327

7094

Neurotic, stress-related and somatoform disorders

2858

13117

1.58

104.11

9.4

10.1

24.38

24.30

mmol/l

0.71

2636

12342

Anxiety disorders

2895

13289

1.57

103.92

9.4

10.1

24.38

24.30

mmol/l

0.72

2672

12499

Benign neoplasm: Colon, unspecified

905

4213

2.25

103.81

8.3

9.0

24.22

24.48

mmol/l

1.55

835

3825

Coronary artery bypass grafting

1232

4841

2.04

103.54

13.4

8.3

24.15

24.30

mmol/l

0.92

1156

4514

Injuries to the thorax

1677

9655

1.80

102.92

10.2

9.1

24.25

24.28

mmol/l

0.17

1562

8963

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

306

812

4.08

102.48

11.2

10.5

24.45

24.21

mmol/l

0.55

279

773

Type 1 diabetes

927

4379

2.20

102.43

13.4

8.7

23.46

24.36

mmol/l

9.86

852

4123

Undetermined asthma, excluding more controls

441

1470

3.16

102.05

9.8

7.7

24.60

23.77

mmol/l

5.79

396

1388

Mental and behavioural disorders due to sedatives or hypnotics

334

949

3.86

101.94

10.7

10.5

24.53

24.30

mmol/l

0.55

307

902

Pleural effusion

688

2911

2.53

101.38

9.7

8.3

24.95

24.04

mmol/l

8.41

640

2668

Non-allergic asthma (mode)

665

2720

2.52

101.11

9.9

8.3

24.97

23.83

mmol/l

15.17

601

2560

Disorders of adult personality and behaviour

913

4324

2.19

100.23

9.4

10.4

24.46

24.19

mmol/l

1.50

827

4094

Unspecified fall

1723

10007

1.76

99.13

10.7

9.1

24.35

24.28

mmol/l

0.35

1633

9273

Disorders of thyroid, IBD co-morbidities

573

1560

2.77

99.02

10.6

8.9

24.37

24.23

mmol/l

0.50

545

1481

Abnormalities of gait and mobility

573

2260

2.75

98.89

9.8

8.9

24.06

24.23

mmol/l

0.59

551

2095

Dizziness and giddiness

2555

13364

1.59

96.57

8.2

9.4

24.45

24.29

mmol/l

1.78

2361

12475

Pain (limb, back, neck, head abdominally)

2645

8407

1.61

96.53

9.9

10.1

24.23

24.22

mmol/l

0.02

2465

7848

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

126

165

10.34

95.73

3.5

8.9

24.19

25.10

mmol/l

2.77

126

152

Benign neoplasm of brain and other parts of central nervous system

309

873

3.90

95.34

7.2

9.1

24.27

24.44

mmol/l

0.44

298

800

Sleep apnoea, including avohilmo

3324

14630

1.50

94.97

8.9

9.7

24.71

24.24

mmol/l

14.54

3086

13702

Congenital malformations, deformations and chromosomal abnormalities

1792

10255

1.71

94.26

10.0

9.9

24.08

24.26

mmol/l

1.51

1711

9612

External causes of morbidity and mortality

2240

6886

1.66

93.39

9.8

9.4

24.23

24.26

mmol/l

0.22

2105

6380

Malignant neoplasm of urinary organs

503

1919

2.87

93.25

8.6

9.1

23.30

24.37

mmol/l

13.18

485

1776

Other diseases of intestine

538

2116

2.73

92.63

14.5

9.0

24.22

24.31

mmol/l

0.27

518

1955

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

625

2542

2.51

91.90

14.3

10.5

23.82

24.23

mmol/l

2.61

612

2392

Other or unspecified ileus, impaction or obstruction

738

3342

2.33

91.88

10.6

8.6

24.14

24.33

mmol/l

0.73

701

3066

Speech therapy

1025

5273

2.03

90.88

9.4

9.2

24.38

24.33

mmol/l

0.20

995

4908

Depression or dysthymia

2474

8845

1.60

90.21

9.0

10.0

24.21

24.22

mmol/l

0.07

2287

8332

Cough

1290

6827

1.86

90.20

8.7

9.6

24.56

24.21

mmol/l

3.57

1200

6462

Factors influencing health status and contact with health services

1171

2992

2.01

90.11

10.7

9.2

24.20

24.43

mmol/l

1.48

1096

2780

Other functional intestinal disorders

1499

8245

1.78

89.71

8.5

8.7

24.55

24.34

mmol/l

1.49

1391

7647

Abnormal findings on examination of blood, without diagnosis

1778

10087

1.71

89.67

9.9

9.3

23.98

24.27

mmol/l

3.25

1671

9349

Injuries to the knee and lower leg

3948

15932

1.44

89.48

9.6

9.5

24.42

24.26

mmol/l

2.13

3693

14850

Sequelae of cerebrovascular disease

1335

6555

1.86

89.08

8.0

8.4

24.25

24.31

mmol/l

0.26

1232

6030

Undetermined asthma

441

1586

2.92

89.07

9.8

8.1

24.60

23.76

mmol/l

5.82

396

1497

Disorders of lens

2492

10171

1.58

88.99

9.5

9.8

24.28

24.29

mmol/l

0.04

2277

9547

Fracture of rib(s), sternum and thoracic spine

1143

6146

1.94

88.72

10.3

9.3

24.33

24.30

mmol/l

0.10

1070

5697

Benign neoplasm: Pituitary gland, craniopharyngeal duct

251

646

4.31

88.65

5.2

10.1

24.09

24.29

mmol/l

0.62

245

595

Concussion

1491

7418

1.78

88.58

9.1

9.9

24.30

24.20

mmol/l

0.52

1386

6945

Malignant neoplasm of kidney, except renal pelvis

465

1751

2.92

88.57

8.1

9.2

23.36

24.34

mmol/l

10.79

449

1624

Disorders resulting from impaired renal tubular function

229

560

4.79

88.25

13.0

12.1

22.93

24.51

mmol/l

10.34

216

532

Disorder of lipoprotein metabolism, unspecified

583

2439

2.55

87.97

10.9

8.4

24.54

24.37

mmol/l

0.54

533

2241

Dysphagia

911

4563

2.08

86.99

8.9

8.5

24.79

24.32

mmol/l

3.75

838

4234

Cellulitis

820

3956

2.17

86.87

10.0

9.7

24.12

24.24

mmol/l

0.46

760

3704

Open wound of head

1831

11105

1.67

86.71

10.0

9.4

24.39

24.28

mmol/l

0.68

1714

10320

Alcoholic liver disease

483

1874

2.80

86.32

13.6

10.5

23.38

24.29

mmol/l

4.84

449

1756

Spinal stenosis

1946

9477

1.66

86.24

7.4

9.4

24.31

24.29

mmol/l

0.14

1795

8850

Benign neoplasm of other and unspecified endocrine glands

548

2254

2.60

86.00

6.8

9.6

24.19

24.29

mmol/l

0.35

527

2114

Type 1 diabetes, wide definition, subgroup 1

725

3339

2.26

85.61

12.7

8.8

23.45

24.35

mmol/l

8.06

653

3151

Alcohol abuse, main dg

628

2741

2.42

85.61

11.2

10.8

24.21

24.16

mmol/l

0.12

582

2581

Clear cell adenocarcinoma of kidney

283

824

3.98

85.35

7.8

10.1

23.55

24.34

mmol/l

4.48

274

766

Visual disturbances and blindness

1699

10325

1.69

85.09

9.2

9.1

24.40

24.32

mmol/l

0.52

1575

9636

Exposure to other specified factors

2372

14566

1.56

85.05

10.0

9.9

24.34

24.28

mmol/l

0.46

2238

13637

Pacemaker

1286

7061

1.85

84.86

12.1

8.0

24.29

24.35

mmol/l

0.23

1172

6502

Other specific joint derangements/joint disorders

2366

10264

1.58

84.60

8.7

10.5

24.25

24.30

mmol/l

0.34

2228

9643

Chronic gastritis

1068

5716

1.95

84.00

9.7

8.1

24.32

24.40

mmol/l

0.32

999

5272

Fungal Sepsis

213

510

4.78

83.71

19.1

8.6

24.47

24.34

mmol/l

0.17

202

471

Acute pancreatitis

794

3845

2.17

83.66

13.5

9.5

23.88

24.27

mmol/l

2.11

747

3555

Chronic pancreatitis

553

2316

2.56

83.64

14.9

9.7

23.72

24.25

mmol/l

2.54

529

2175

Emergency coronary revascularization (for ACS)

2136

9812

1.61

83.18

10.8

8.6

24.12

24.33

mmol/l

2.22

1963

9078

Low back pain

2409

12200

1.55

82.14

8.7

10.0

24.56

24.23

mmol/l

5.41

2236

11453

Diseases of oral cavity, salivary glands and jaws

3177

11172

1.48

81.79

9.5

9.0

24.17

24.30

mmol/l

1.41

2964

10369

Genitourinary diseases

2159

6815

1.62

81.56

11.9

10.2

23.94

24.41

mmol/l

9.10

2026

6398

Benign neoplasm: Sigmoid colon

656

2980

2.32

81.32

9.4

9.2

24.11

24.48

mmol/l

2.02

614

2726

Decubitus ulcer and pressure area

313

993

3.51

81.28

11.1

8.5

24.78

24.50

mmol/l

0.63

293

910

Visual disturbances

1564

9421

1.71

81.13

9.3

9.2

24.43

24.30

mmol/l

0.83

1459

8810

Specific personality disorders

736

3499

2.18

80.21

9.7

10.3

24.47

24.20

mmol/l

1.31

662

3313

Implicit fungal Sepsis

199

468

4.89

80.18

19.0

8.7

24.43

24.41

mmol/l

0.03

191

431

Deposits [accretions] on teeth

325

1014

3.36

80.15

19.8

11.1

23.93

24.32

mmol/l

1.23

317

959

Selective serotonin reuptake inhibitors

3430

12647

1.45

79.21

8.8

9.7

24.40

24.21

mmol/l

2.59

3164

11861

Mental and behavioural disorders due to use of other stimulants, including caffeine

149

274

6.10

79.19

12.3

12.5

24.54

23.99

mmol/l

0.93

134

262

Chronic viral hepatitis

244

665

4.01

79.13

11.1

11.3

24.37

24.24

mmol/l

0.21

227

633

Mental and behavioural disorders due to opioids

186

415

4.96

79.00

13.5

10.9

24.91

24.06

mmol/l

2.39

172

395

Fracture of lower leg, including ankle

1814

11358

1.63

78.90

10.2

9.5

24.29

24.31

mmol/l

0.09

1698

10604

Brain glioblastoma

126

206

8.20

78.64

3.5

10.1

24.19

24.63

mmol/l

1.06

126

194

Other complications of surgical and medical care, not elsewhere classified

393

1431

2.94

78.58

13.3

9.0

24.19

24.26

mmol/l

0.17

378

1330

Acute alcohol intoxication

966

5114

1.96

78.45

10.4

9.4

24.20

24.17

mmol/l

0.08

897

4756

Disorders of other endocrine glands

1399

8110

1.74

78.43

9.1

24.10

24.32

mmol/l

1.72

1312

7562

Dorsalgia

3299

12485

1.45

77.59

8.3

9.9

24.42

24.22

mmol/l

2.78

3047

11712

Other symptoms and signs involving cognitive functions and awareness

1577

9023

1.69

77.43

6.8

8.9

24.41

24.26

mmol/l

0.95

1427

8387

Fracture of shoulder and upper arm

1235

7075

1.80

77.04

9.6

9.1

24.35

24.31

mmol/l

0.14

1161

6575

Persons with potential health hazards related to communicable diseases

1062

5755

1.88

76.81

13.3

10.3

24.20

24.08

mmol/l

0.66

992

5438

Amputation of toe

363

1299

3.09

76.38

12.1

9.5

24.05

24.28

mmol/l

0.55

331

1204

Fracture of lumbar spine and pelvis

802

4023

2.08

76.29

8.6

8.0

24.41

24.29

mmol/l

0.41

747

3708

In situ neoplasms

1060

5540

1.88

76.03

8.2

8.1

24.30

24.46

mmol/l

0.86

1012

5029

Emotionally unstable personality disorder

381

1381

2.88

75.83

8.2

10.1

24.23

24.09

mmol/l

0.37

355

1320

Other disorders of teeth and supporting structures

777

3862

2.10

75.83

11.4

9.0

24.32

24.35

mmol/l

0.09

716

3595

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

716

3459

2.17

75.81

8.6

8.9

23.97

24.45

mmol/l

3.85

690

3136

Senile cataract

2285

9324

1.56

75.62

9.3

9.8

24.31

24.30

mmol/l

0.05

2099

8737

Acute pancreatitis (for exclusion)

794

3993

2.09

75.54

13.5

9.7

23.88

24.25

mmol/l

1.96

747

3702

Persons encountering health services for examination and investigation

2297

7493

1.56

75.28

10.2

9.7

24.22

24.36

mmol/l

1.22

2118

7037

Diabetic nephropathy

721

3500

2.18

74.21

12.7

10.7

23.22

24.09

mmol/l

8.37

666

3185

Traumatic subdural haemorrhage

531

2256

2.45

74.03

9.6

8.6

23.67

24.23

mmol/l

2.91

494

2076

Other bacterial intestinal infections

676

3228

2.19

73.74

10.8

8.8

24.10

24.29

mmol/l

0.69

616

2979

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

799

4057

2.06

73.71

6.9

9.2

24.62

24.46

mmol/l

0.69

763

3711

Parodontitis or/and operation codes

1993

7579

1.60

73.68

10.6

9.6

24.16

24.35

mmol/l

1.81

1879

7099

Exclusions for E4_PCOS_BROAD

612

2810

2.28

73.52

8.7

10.3

24.09

24.27

mmol/l

0.82

578

2638

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3238

14940

1.44

73.46

9.5

24.33

24.31

mmol/l

0.16

3003

13922

Other viral hepatitis

269

820

3.54

73.42

12.3

12.0

24.32

24.26

mmol/l

0.09

250

782

Used for control exclusion in common control thyroid runs

3545

12821

1.42

73.30

10.2

9.5

24.06

24.30

mmol/l

3.90

3277

12020

Intestinal adhesions without obstruction

371

1368

2.93

72.93

11.0

8.5

24.38

24.40

mmol/l

0.02

352

1276

Other neurological diseases

2479

13561

1.50

72.85

8.7

9.0

24.30

24.33

mmol/l

0.21

2303

12587

Acute alcohol intoxication, ICD10

740

3671

2.11

72.78

10.9

10.3

24.14

24.19

mmol/l

0.11

690

3452

Enterocolitis due to Clostridium difficile

455

1856

2.62

72.67

11.2

8.8

23.98

24.38

mmol/l

1.42

413

1707

Other CVD

759

3812

2.10

72.63

8.8

8.2

24.51

24.28

mmol/l

0.97

679

3490

Benign neoplasm: Rectum, anus and anal canal

685

3308

2.17

72.54

8.6

9.0

24.33

24.47

mmol/l

0.51

633

3025

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

285

907

3.39

72.50

8.8

10.1

24.23

24.32

mmol/l

0.14

268

857

Other disorders of kidney and ureter

541

2391

2.42

72.39

11.5

9.1

23.56

24.27

mmol/l

5.66

512

2231

Allergic asthma (mode), excluding more controls

607

2724

2.24

72.14

9.4

8.0

24.37

23.80

mmol/l

4.43

555

2575

Angina pectoris

2106

9332

1.56

71.85

9.7

8.8

24.36

24.39

mmol/l

0.16

1927

8745

Type 1 diabetes, wide definition

741

3682

2.08

71.65

12.8

8.8

23.46

24.34

mmol/l

7.92

666

3464

Thoracic aortic aneurysm

586

2693

2.32

71.51

13.2

9.4

24.21

24.27

mmol/l

0.19

557

2502

Intracranial injury

1862

11633

1.58

71.29

9.6

9.0

24.17

24.27

mmol/l

0.63

1730

10805

Nontraumatic intracranial haemmorrhage

764

3875

2.06

70.72

10.8

8.5

24.34

24.32

mmol/l

0.05

721

3559

Complications of internal orthopaedic prosthetic devices, implants and grafts

817

4244

2.01

70.63

9.4

7.8

24.37

24.42

mmol/l

0.15

772

3903

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1068

6025

1.83

70.39

8.8

9.1

24.40

24.34

mmol/l

0.29

998

5650

Endocarditis

190

476

4.49

70.08

17.8

8.1

24.26

24.44

mmol/l

0.34

180

449

Oesophageal varices

236

694

3.86

69.70

13.4

10.9

23.08

24.29

mmol/l

5.00

227

658

Lower back pain or/and sciatica

3303

16493

1.41

69.02

8.5

9.7

24.49

24.27

mmol/l

3.79

3054

15409

Cirrhosis of liver, NAS

268

860

3.50

68.67

13.1

10.7

23.47

24.42

mmol/l

4.09

251

809

Open wound of lower leg

541

2434

2.34

68.63

9.8

9.6

24.87

24.25

mmol/l

4.16

513

2271

Benign neoplasm: Pituitary gland, craniopharyngeal duct

251

770

3.59

68.51

5.2

11.1

24.09

24.27

mmol/l

0.57

245

727

Other cataract

1550

7471

1.65

68.13

9.1

9.3

24.35

24.29

mmol/l

0.28

1408

6990

Acute upper respiratory infections of multiple and unspecified sites

2321

11805

1.50

67.58

10.2

9.6

24.52

24.22

mmol/l

4.21

2146

11044

Mental and behavioural disorders due to tobacco

359

1355

2.85

67.43

7.7

10.4

24.94

24.24

mmol/l

3.45

320

1281

Bacterial intestinal infections, IBD co-morbidities

677

3349

2.12

67.27

10.8

8.7

24.08

24.25

mmol/l

0.61

619

3093

Fibrosis and cirrhosis of liver

345

1285

2.93

67.02

12.8

9.5

23.50

24.39

mmol/l

4.63

326

1204

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

494

2162

2.42

66.93

9.9

8.2

23.38

24.32

mmol/l

9.78

468

1935

Smoking dependency

359

1363

2.83

66.67

7.7

10.4

24.95

24.25

mmol/l

3.40

320

1287

Gastroduodenal ulcer

988

5534

1.85

66.59

10.5

8.3

23.90

24.30

mmol/l

2.78

894

5084

Benign neoplasm of other and ill-defined parts of digestive system

586

2761

2.22

66.16

10.6

8.7

24.41

24.50

mmol/l

0.27

542

2531

Benign neoplasm of brain and other parts of central nervous system

309

1098

3.07

65.55

7.2

10.0

24.27

24.37

mmol/l

0.24

298

1033

Other/unspecified dorsalgia

1217

7235

1.72

64.96

8.3

9.5

24.49

24.28

mmol/l

1.56

1145

6773

Spondylosis

1846

10405

1.56

64.92

7.5

9.8

24.48

24.29

mmol/l

1.86

1716

9763

Benign neoplasm: Rectum

604

2904

2.18

64.89

8.8

9.3

24.36

24.49

mmol/l

0.41

555

2669

Ascites

320

1164

2.98

64.73

13.4

8.5

23.40

24.24

mmol/l

3.02

302

1078

Abdominal aortic aneurysm (AAA)

462

1982

2.46

64.72

12.7

7.1

24.30

24.18

mmol/l

0.35

428

1798

Attention to artificial openings

211

604

3.93

64.60

11.3

10.0

24.37

24.45

mmol/l

0.11

202

558

Injury, poisoning and certain other consequences of external causes

1740

5516

1.61

64.35

9.7

9.2

24.28

24.23

mmol/l

0.29

1638

5127

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

612

2969

2.16

64.21

8.9

9.2

24.27

24.44

mmol/l

0.74

587

2715

Unspecified acute lower respiratory infection

550

2560

2.25

64.11

11.8

10.1

24.58

24.24

mmol/l

1.42

507

2387

Malignant neoplasm of respiratory system and intrathoracic organs

855

4271

1.92

63.97

8.5

7.9

24.93

24.14

mmol/l

12.13

823

3885

Recurrent or chronic depression

1164

4914

1.75

63.40

9.0

10.5

24.18

24.25

mmol/l

0.33

1087

4672

Hypotension

646

3219

2.11

63.36

8.9

8.0

24.56

24.26

mmol/l

1.24

572

2942

Cerebral palsy and other paralytic syndromes

443

1898

2.47

63.24

9.3

9.9

24.59

24.26

mmol/l

1.12

417

1776

155

364

5.00

63.13

6.7

10.7

25.27

24.29

mmol/l

2.81

140

337

Pneumothorax

317

1163

2.95

63.07

11.4

9.4

24.62

24.05

mmol/l

2.19

304

1085

Other congenital malformations of circulatory system

157

373

4.88

62.74

8.7

11.0

24.37

24.42

mmol/l

0.06

151

352

Dental pulpitis 1

3540

13484

1.38

62.65

9.6

9.3

24.18

24.31

mmol/l

1.58

3294

12587

Viral hepatitis

294

1036

3.03

62.61

12.0

11.5

24.30

24.34

mmol/l

0.07

275

987

Elevated blood glucose level

353

1372

2.76

62.58

11.4

9.9

23.70

24.34

mmol/l

2.45

333

1283

Disorders of choroid and retina

2725

14094

1.43

62.58

9.4

9.1

24.06

24.37

mmol/l

4.89

2503

13127

Diseases of pulp and periapical tissues, including avohilmo

3532

13450

1.38

62.56

9.6

9.3

24.19

24.31

mmol/l

1.32

3287

12555

Superficial injury of head

754

3963

1.97

62.44

9.0

8.7

24.41

24.28

mmol/l

0.46

706

3683

Dental pulpitis 4

3538

13485

1.38

62.29

9.6

9.3

24.18

24.32

mmol/l

1.54

3291

12589

Allergic asthma (mode)

607

2898

2.10

61.63

9.4

8.4

24.37

23.80

mmol/l

4.40

555

2740

Injuries to the shoulder and upper arm

2705

16187

1.42

61.47

9.1

9.5

24.38

24.30

mmol/l

0.61

2541

15084

Haemorrhage, not elsewhere classified

191

528

4.04

61.38

13.6

9.2

23.91

24.28

mmol/l

0.68

170

494

Other diseases of pericardium

207

603

3.78

61.23

14.6

8.9

24.58

24.29

mmol/l

0.62

198

569

Soft tissue disorders

3332

12614

1.39

61.09

9.1

9.9

24.17

24.27

mmol/l

0.96

3095

11785

Other special examinations and investigations of persons without complaint or reported diagnosis

2195

7492

1.51

61.09

9.9

9.7

24.18

24.36

mmol/l

1.74

2008

7037

Diseases of the eye and adnexa

2595

9056

1.45

60.93

10.5

10.6

24.07

24.25

mmol/l

1.93

2419

8547

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

276

962

3.12

60.57

9.0

7.7

24.96

24.34

mmol/l

2.98

267

875

Suppurative and necrotic conditions of lower respiratory tract

271

939

3.18

60.48

13.1

10.3

25.25

24.29

mmol/l

3.63

253

880

Autoimmune diseases

3647

13794

1.37

60.30

10.5

9.4

24.05

24.32

mmol/l

4.91

3362

12929

Benign neoplasm: Ascending colon

459

2045

2.37

59.98

7.9

8.8

24.29

24.46

mmol/l

0.52

412

1879

Bipolar affective disorders

560

2690

2.15

59.53

9.0

10.3

24.38

24.23

mmol/l

0.53

507

2545

Other specified and unspecified personality disorders

325

1237

2.77

59.41

11.3

10.4

24.79

24.19

mmol/l

2.11

295

1180

Diagnoses used for exclusion with ILD

914

5191

1.82

59.35

11.8

8.9

24.62

24.27

mmol/l

2.26

850

4782

Schizophrenia or delusion, excluding more controls

882

4899

1.83

59.20

8.9

9.9

24.84

24.29

mmol/l

4.55

779

4635

ILD medications: azathioprine

486

2218

2.28

59.17

15.3

9.7

24.09

24.11

mmol/l

0.05

447

2086

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

384

1592

2.56

59.07

11.2

9.2

25.00

24.36

mmol/l

3.76

362

1450

Other gastritis (incl. Duodenitis)

819

4510

1.89

59.01

9.8

8.7

24.07

24.34

mmol/l

1.39

749

4184

Benign neoplasm: Colon, unspecified

905

5159

1.83

58.46

8.3

8.7

24.22

24.34

mmol/l

0.54

835

4797

Finngen Rheumatological endpoints

3055

12648

1.40

58.41

9.5

9.8

24.26

mmol/l

0.01

2833

11832

Poisoning by narcotics and psychodysleptics [hallucinogens]

163

6.94

58.26

11.0

10.9

23.87

24.46

mmol/l

0.75

150

Alcohol withdrawal state with delirium

326

1270

2.78

57.97

12.3

10.7

24.40

24.24

mmol/l

0.26

304

1202

Endovascular or surgical operations to intracerebral aneurysms

279

1001

3.02

57.95

7.8

10.0

24.12

24.44

mmol/l

1.13

266

930

Myocarditis

168

436

4.10

57.86

20.9

8.0

24.28

24.29

mmol/l

0.01

157

410

Malignant neoplasm of digestive organs

1358

8477

1.63

57.73

9.5

8.4

24.04

24.33

mmol/l

2.70

1316

7784

Missing teeth due to accident, extraction or parodontitis

441

1980

2.35

56.57

11.9

9.2

24.37

24.34

mmol/l

0.06

410

1847

Other pleural conditions

419

1846

2.42

56.52

9.8

8.4

24.92

24.06

mmol/l

4.79

379

1690

Lung diseases due to external agents

549

2688

2.15

56.49

11.0

8.5

24.72

24.27

mmol/l

1.98

510

2471

Idiopathic gout

407

1779

2.47

56.47

9.8

9.7

23.87

24.27

mmol/l

1.29

383

1652

All influenza (not pneumonia)

484

2248

2.24

56.39

10.6

9.1

24.60

23.98

mmol/l

3.81

445

2111

Bronchiectasis

323

1269

2.73

56.09

7.6

8.8

25.29

24.13

mmol/l

6.98

293

1186

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

276

1001

2.97

56.07

9.8

9.0

24.50

24.38

mmol/l

0.25

270

916

severe traumatic brain injury, does not include concussion

807

4501

1.86

55.94

10.4

8.7

24.01

24.31

mmol/l

1.54

752

4138

Other dorsopathies, not elsewhere classified

3227

12532

1.38

55.88

8.7

10.0

24.40

24.22

mmol/l

2.50

2980

11757

Other diseases of liver

605

3074

2.05

55.80

11.3

9.4

24.17

24.34

mmol/l

0.57

566

2875

Assault

420

1851

2.36

55.66

11.7

11.2

23.81

24.21

mmol/l

1.53

399

1754

Polyneuropathies and other disorders of the peripheral nervous system

798

4450

1.87

55.56

9.3

9.4

24.03

24.28

mmol/l

1.06

727

4135

Sub-endpoint used in defining T1D endpoints

984

5703

1.74

55.41

12.9

9.2

23.50

24.26

mmol/l

7.93

893

5280

Diseases of the myoneural junction and muscle

468

2175

2.28

55.32

11.5

9.5

24.74

24.32

mmol/l

1.54

433

2029

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

208

650

3.51

55.13

11.8

8.8

25.03

24.44

mmol/l

2.44

197

603

Alcohol-induced chronic pancreatitis

298

1140

2.84

54.96

17.2

11.0

23.60

24.28

mmol/l

1.97

283

1082

Mixed and other personality disorders

283

1045

2.86

54.95

7.6

10.8

24.47

24.25

mmol/l

0.43

263

995

Other diseases of anus and rectum

960

5636

1.75

54.91

8.7

8.5

24.21

24.35

mmol/l

0.64

898

5209

Left ventricular outflow tract obstruction (LVOTO), broad definition

398

1736

2.43

54.85

18.8

12.1

24.50

24.29

mmol/l

0.90

373

1658

Overexertion and strenuous or repetitive movements

376

1597

2.49

54.84

10.4

10.2

24.21

24.31

mmol/l

0.21

359

1504

Osteoporosis

845

4572

1.83

54.74

8.8

7.5

24.94

24.44

mmol/l

3.10

755

4230

Pneumonia due to other infectious organisms, not elsewhere classified

152

389

4.33

54.33

9.6

24.35

24.04

mmol/l

0.62

140

360

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

329

1321

2.64

54.24

10.1

9.2

24.39

24.24

mmol/l

0.36

316

1224

Acidosis

123

271

5.31

54.15

13.5

9.5

21.78

24.55

mmol/l

4.83

111

255

Non-selective monoamine reuptake inhibitors

1231

7496

1.63

53.96

8.2

9.0

24.59

24.31

mmol/l

2.12

1141

7007

Fall on and from stairs and steps

829

4704

1.82

53.92

9.5

9.2

24.31

24.32

mmol/l

0.02

773

4398

Symptoms and signs involving the skin and subcutaneous tissue

2096

14657

1.45

53.40

9.0

9.3

24.35

24.32

mmol/l

0.14

1962

13668

Delirium, not induced by alcohol and other psychoactive substances

451

2098

2.27

53.10

13.0

8.3

24.44

24.40

mmol/l

0.08

414

1930

Persistent mood disorders

627

3273

1.98

53.09

8.3

9.4

24.27

24.30

mmol/l

0.10

574

3072

Fracture of skull and facial bones

699

3784

1.91

53.00

10.9

9.6

24.17

24.23

mmol/l

0.16

646

3540

Coagulation defects, purpura and other haemorrhagic conditions

639

3368

1.97

52.84

11.3

9.1

23.92

24.23

mmol/l

1.63

609

3130

Hernia of abdominal wall

1509

10003

1.55

52.44

10.1

9.4

24.34

24.29

mmol/l

0.23

1402

9339

Pneumocystosis

116

253

5.60

52.38

11.3

10.0

24.20

24.58

mmol/l

0.68

111

237

Azathioprine

486

2329

2.17

52.35

15.3

9.8

24.09

24.08

mmol/l

0.02

447

2192

Autoimmune diseases related-to ILD

2569

16441

1.39

52.30

10.0

9.5

24.26

24.29

mmol/l

0.21

2377

15368

Vascular disorders of the intestines

287

1104

2.80

52.08

16.0

8.1

23.65

24.47

mmol/l

3.01

262

1006

Other and unspecified polyneuropathies, also in other diseases

705

3866

1.91

52.00

9.1

9.3

23.99

24.27

mmol/l

1.12

643

3583

Other disorders of glucose regulation and pancreatic internal secretion

332

1368

2.58

51.91

13.4

9.9

24.13

24.26

mmol/l

0.21

296

1280

Nonischemic cardiomyopathy

257

938

2.97

51.90

19.9

9.7

24.08

24.28

mmol/l

0.39

242

883

Benign neoplasm: Adrenal gland

274

1031

2.85

51.82

8.3

9.5

24.23

24.36

mmol/l

0.24

261

951

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1634

7447

1.53

51.49

7.9

9.4

24.26

24.45

mmol/l

1.57

1520

6781

Polyuria

774

4371

1.84

51.45

7.9

9.2

24.51

24.26

mmol/l

1.25

725

4062

Benign neoplasm: Transverse colon

361

1553

2.47

51.40

8.1

9.2

24.25

24.37

mmol/l

0.27

330

1421

Asthma and opportunity respiratory infection

215

718

3.29

51.21

8.3

9.0

25.39

24.22

mmol/l

5.66

199

668

Other and unspecified nonorganic psychotic disorders

571

2921

2.02

51.13

9.6

10.6

24.62

24.17

mmol/l

2.30

505

2762

Iron deficiency anaemia secondary to blood loss (chronic)

559

2851

2.05

51.10

11.5

8.3

23.88

24.30

mmol/l

2.09

513

2637

Cholelithiasis, broad definition with cholecystitis

2715

13635

1.39

51.09

9.2

8.9

24.26

24.37

mmol/l

1.06

2532

12654

Gastric ulcer

660

3560

1.93

51.01

10.3

8.3

24.05

24.35

mmol/l

1.32

608

3263

Congenital malformations of heart and great arteries

433

1943

2.26

50.79

17.7

10.9

24.23

24.20

mmol/l

0.08

422

1846

Behavioural syndromes associated with physiological disturbances and physical factors

856

4967

1.76

50.77

9.0

9.9

24.41

24.17

mmol/l

1.37

782

4674

Other aneurysm

253

928

2.97

50.72

11.6

8.7

24.32

24.27

mmol/l

0.09

242

857

Injuries to the ankle and foot

1942

12350

1.45

50.45

9.4

10.1

24.30

24.25

mmol/l

0.33

1830

11595

Other retinal disorders

2089

11872

1.44

50.13

9.3

8.8

24.00

24.38

mmol/l

5.62

1910

11018

Persons encountering health services in other circumstances

1064

6561

1.66

50.05

8.7

9.1

24.57

24.27

mmol/l

2.12

997

6097

Memory loss

389

1754

2.37

50.00

6.0

8.3

24.58

24.40

mmol/l

0.46

350

1624

Benign neoplasm: Caecum

360

1567

2.44

49.90

9.7

8.9

24.17

24.44

mmol/l

0.89

333

1440

Osteomyelitis

280

1093

2.77

49.55

11.2

9.7

24.11

24.23

mmol/l

0.18

264

1030

Special screening examination for infectious and parasitic diseases

666

2665

1.91

48.94

9.5

10.3

24.10

24.21

mmol/l

0.38

629

2551

Nerve, nerve root and plexus disorders

3342

15951

1.33

48.65

8.9

9.6

24.31

mmol/l

0.01

3094

14883

KRA_PSY_EATING, excluding more controls

185

570

3.34

48.49

8.7

9.1

24.40

23.92

mmol/l

0.94

170

549

Panic disorder

392

1776

2.28

48.35

11.6

9.8

24.53

24.18

mmol/l

1.24

356

1683

Primary_lymphoid and hematopoietic malignant neoplasms

736

4166

1.82

48.24

10.1

9.1

24.20

24.42

mmol/l

0.98

685

3793

Colorectal cancer

836

4923

1.76

48.14

8.6

8.7

23.95

24.33

mmol/l

3.12

807

4534

Alcohol-induced acute pancreatitis

187

600

3.47

47.93

15.0

12.4

23.37

24.41

mmol/l

2.82

179

574

Other and unspecified drugs and medicaments

315

1319

2.54

47.67

10.1

10.0

24.40

24.31

mmol/l

0.17

302

1237

Pericarditis

158

457

3.77

47.18

11.1

9.0

24.42

24.30

mmol/l

0.16

149

431

Aortic valve malfunction, age under 60 years

363

1627

2.37

47.05

16.7

11.6

24.52

24.29

mmol/l

0.94

339

1557

Other headache syndromes

1143

7294

1.60

46.70

9.1

9.5

24.50

24.29

mmol/l

1.50

1058

6823

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

408

1920

2.23

46.62

8.3

7.9

23.84

24.48

mmol/l

3.67

396

1732

Benign neoplasm: Sigmoid colon

656

3642

1.88

46.54

9.4

8.9

24.11

24.31

mmol/l

0.80

614

3387

Malignant neoplasm of bronchus and lung

706

3739

1.84

46.28

7.8

7.7

24.93

24.21

mmol/l

8.97

678

3391

Other metabolic disorders

377

1720

2.28

46.04

10.8

8.4

24.49

24.35

mmol/l

0.38

355

1608

Dental caries 1

2640

9925

1.38

46.00

9.1

9.2

24.28

24.31

mmol/l

0.17

2457

9229

Subjective visual disturbances

743

4281

1.79

45.85

8.4

8.9

24.48

24.37

mmol/l

0.46

685

4019

Ventral hernia

784

4591

1.76

45.79

10.5

8.9

24.39

24.34

mmol/l

0.14

737

4297

Progressive vascular leukoencephalopathy

171

537

3.57

45.58

4.4

7.1

24.18

24.72

mmol/l

1.20

158

486

Dental pulpitis 4, only avohilmo

3503

14048

1.32

45.47

9.2

9.5

24.24

24.29

mmol/l

0.49

3267

13119

Other and unspecified effects of external causes

774

4516

1.76

45.37

10.8

9.9

24.15

24.18

mmol/l

0.09

738

4238

Colorectal adenocarcinoma

716

4110

1.81

45.33

8.6

8.7

23.97

24.31

mmol/l

2.24

690

3786

Other disorders of veins

1178

7634

1.58

45.23

8.2

8.8

24.66

24.38

mmol/l

2.18

1095

7141

Exclusions for E4_PCOS_CONSORTIUM

1893

8321

1.45

45.18

8.4

9.3

24.33

24.38

mmol/l

0.27

1776

7793

Dental caries, including avohilmo

2632

9921

1.38

45.17

9.1

9.2

24.28

24.31

mmol/l

0.17

2449

9225

Other and unspecified mood [affective] disorders

216

766

2.95

45.10

9.7

10.0

23.75

24.26

mmol/l

1.39

199

728

Use of disulfiram, acamprosate or naltrexone

333

1466

2.40

44.93

11.2

11.7

24.15

24.29

mmol/l

0.29

307

1393

Asthma and allergy, excluding more controls

307

1279

2.43

44.48

9.2

7.4

24.53

23.68

mmol/l

4.93

283

1207

Toxic effect of other and unspecified substances

136

6.63

44.32

12.8

12.4

23.97

24.50

mmol/l

0.60

129

Transport accidents

1266

7384

1.54

44.24

9.6

9.7

24.32

24.22

mmol/l

0.46

1193

6880

Mental and behavioural disorders due to cannabinoids

116

282

4.43

44.01

12.4

11.9

24.39

23.97

mmol/l

0.53

110

269

Misadventures to patients during surgical and medical care

468

2367

2.06

43.91

12.1

8.8

23.93

24.23

mmol/l

1.09

441

2196

Generalized anxiety disorder

383

1788

2.20

43.86

8.1

9.7

24.25

24.17

mmol/l

0.21

352

1702

Other local infections of skin and subcutaneous tissue

363

1672

2.28

43.84

12.1

9.7

24.16

24.29

mmol/l

0.35

337

1575

Injuries to unspecified part of trunk, limb or body region

358

1642

2.30

43.73

11.4

9.8

24.31

24.26

mmol/l

0.11

345

1536

Gastro-oesophageal reflux disease

2063

13227

1.40

43.70

9.2

9.1

24.50

24.36

mmol/l

1.24

1915

12363

Symptoms and signs involving speech and voice

1006

6350

1.63

43.64

10.0

8.7

24.46

24.33

mmol/l

0.65

933

5922

Dental caries 3

2747

10479

1.36

43.59

8.9

9.3

24.28

24.31

mmol/l

0.16

2566

9738

Arterial embolism and thrombosis

246

960

2.75

43.38

13.4

7.6

23.91

24.30

mmol/l

0.85

221

879

Sequelae of injuries, of poisoning and of other consequences of external causes

742

4342

1.76

43.34

10.5

10.0

24.19

24.26

mmol/l

0.23

703

4073

Dental pulpitis 1, only avohilmo

3495

14112

1.31

43.20

9.2

9.5

24.24

24.29

mmol/l

0.39

3260

13179

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

355

1631

2.29

43.19

8.8

9.0

24.12

24.39

mmol/l

0.97

341

1486

Other embolism and thrombosis

459

2323

2.07

43.09

12.4

9.5

24.09

24.33

mmol/l

0.82

430

2164

Pneumonitis due to solids and liquids

321

1420

2.40

42.98

13.5

8.5

24.88

24.21

mmol/l

2.13

298

1298

Amputation of foot

145

429

3.87

42.81

11.2

10.9

23.93

24.46

mmol/l

0.98

136

400

Dorsopathies

3223

12587

1.32

42.78

8.8

10.0

24.29

24.22

mmol/l

0.65

2979

11811

Other and unspecified local infections of skin and subcutaneous tissue

341

1549

2.32

42.66

12.4

9.8

24.13

24.28

mmol/l

0.40

317

1457

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

243

951

2.73

42.62

11.2

8.3

23.78

24.27

mmol/l

1.68

234

861

Insulin, fast-acting (human)

447

2247

2.06

42.31

13.5

9.3

23.19

24.34

mmol/l

8.82

405

2115

Sciatica+with lumbago

1512

9914

1.47

42.20

8.1

10.0

24.45

24.28

mmol/l

1.26

1391

9344

Symptoms and signs concerning food and fluid intake

338

1532

2.30

42.11

8.8

9.3

24.43

24.22

mmol/l

0.39

299

1437

Hypoglycaemia, other or unspecified

260

1056

2.62

42.07

14.0

10.3

23.84

24.28

mmol/l

0.91

233

991

Non-small cell lung cancer, adenocarcinoma, helper endpoint

276

1161

2.56

41.91

9.0

8.4

24.96

24.31

mmol/l

3.60

267

1081

Non-small cell lung cancer, adenocarcinoma

276

1161

2.56

41.91

9.0

8.4

24.96

24.31

mmol/l

3.60

267

1081

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

343

1574

2.30

41.87

8.7

24.09

24.38

mmol/l

1.04

329

1432

Protozoal diseases

141

414

3.82

41.77

10.8

11.2

24.19

24.47

mmol/l

0.50

132

387

Other diseases of biliary tract

330

1496

2.34

41.71

12.8

9.0

23.92

24.40

mmol/l

1.93

318

1378

Mycoses

818

4974

1.69

41.42

11.7

9.2

24.26

24.27

mmol/l

0.03

743

4653

Cholelithiasis

2549

13413

1.35

41.39

9.1

8.8

24.26

24.38

mmol/l

1.02

2380

12445

Unstable angina pectoris

1316

7353

1.52

41.38

8.5

8.2

24.30

24.39

mmol/l

0.41

1175

6848

Congenital malformations of cardiac septa

234

877

2.73

41.28

17.6

11.5

24.52

24.26

mmol/l

0.72

229

831

Hypertensive Renal Disease

154

479

3.49

41.07

8.7

8.2

23.97

24.34

mmol/l

0.59

140

446

Other diseases of blood and blood-forming organs, wide

705

4136

1.76

41.03

11.0

9.2

24.41

24.29

mmol/l

0.41

675

3860

Nonorganic sleeping disorders, excluding more controls

478

2485

1.98

40.87

9.6

9.8

24.29

24.25

mmol/l

0.09

436

2343

Dental pulpitis 2

2357

8891

1.38

40.75

9.0

24.21

24.31

mmol/l

0.78

2187

8263

Pyothorax

196

709

3.03

40.58

14.5

10.4

25.40

24.33

mmol/l

3.59

183

667

Congenital malformations of the urinary system

219

834

2.80

40.49

7.7

11.0

22.97

24.29

mmol/l

6.83

214

791

Dental pulpitis 2, only avohilmo

2405

9109

1.37

40.39

9.0

9.2

24.22

24.31

mmol/l

0.71

2230

8467

Asthma and allergy

307

1335

2.33

40.38

9.2

8.0

24.53

23.68

mmol/l

4.85

283

1263

Intracerebral haemorrhage

458

2372

2.02

40.32

12.1

8.1

24.47

24.31

mmol/l

0.46

429

2161

Cystic kidney disease

150

467

3.53

40.23

6.6

11.2

22.57

24.48

mmol/l

8.90

145

440

Other and unspecified myopathies

329

1513

2.31

40.21

12.4

9.2

24.75

24.35

mmol/l

0.97

304

1411

Other noninfective gastroenteritis and colitis

742

4430

1.72

40.07

10.3

9.2

24.26

24.27

mmol/l

0.02

694

4131

Phlebitis and thrombophlebitis (not including DVT)

721

4284

1.74

39.99

8.7

9.2

24.29

24.28

mmol/l

0.02

678

3996

Other arthrosis

1700

8609

1.44

39.94

8.9

10.2

24.27

24.38

mmol/l

0.80

1563

8061

Superficial injury of lower leg

699

4112

1.74

39.90

9.5

24.62

24.27

mmol/l

2.16

664

3844

Disturbances of skin sensation

755

4533

1.71

39.90

8.5

9.7

24.39

24.25

mmol/l

0.68

716

4268

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

175

599

3.17

39.82

9.4

9.3

24.23

24.29

mmol/l

0.08

170

552

Hypertension, Pulmonary Arterial

8.01

39.75

23.4

6.7

24.02

24.54

mmol/l

0.46

Benign neoplasm: Rectum, anus and anal canal

685

4030

1.76

39.73

8.6

8.9

24.33

24.31

mmol/l

0.06

633

3735

Other intervertebral disc disorders

2586

11936

1.34

39.66

9.8

9.9

24.40

24.25

mmol/l

1.50

2378

11194

Enlarged lymph nodes

465

2437

1.97

39.02

10.7

9.6

24.43

24.28

mmol/l

0.47

438

2285

Glomerulonephritis

371

1809

2.16

38.85

12.4

10.1

23.61

24.28

mmol/l

3.33

346

1704

ILD medications: pirfenidone

170

6.07

38.77

16.4

11.4

24.97

24.50

mmol/l

0.83

159

Disorders of mineral metabolism

277

1206

2.42

38.35

10.2

8.5

23.99

24.42

mmol/l

1.03

260

1124

Heart failure and hypertrophic cardiomyopathy

108

283

4.46

38.27

20.3

10.9

24.34

24.57

mmol/l

0.30

103

266

Coronary angioplasty

1265

6591

1.51

38.03

8.3

8.5

24.05

24.37

mmol/l

2.57

1132

6162

Soft tissue disorders related to use, overuse and pressure

834

5210

1.64

37.88

8.7

9.5

24.43

24.35

mmol/l

0.32

768

4871

Systemic connective tissue disorders

1036

6802

1.56

37.75

10.2

8.3

24.40

24.38

mmol/l

0.06

956

6331

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1425

6763

1.47

37.63

7.7

9.1

24.22

24.47

mmol/l

2.22

1321

6137

Mental disorders, not otherwise specified

252

1058

2.49

37.58

10.6

10.5

24.21

24.17

mmol/l

0.08

233

1010

Vascular diseases of the intestine

172

605

3.10

37.41

20.2

8.3

23.51

24.49

mmol/l

2.21

156

557

Benign neoplasm of other and ill-defined parts of digestive system

586

3357

1.81

37.36

10.6

8.7

24.41

24.33

mmol/l

0.27

542

3128

Dental caries 1 and operation codes

2864

11286

1.32

37.28

9.2

24.25

24.30

mmol/l

0.35

2694

10463

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

285

1275

2.36

37.17

7.7

8.2

24.20

24.39

mmol/l

0.39

265

1160

Subarachnoid haemorrhage

371

1838

2.11

37.14

10.0

8.9

24.17

24.40

mmol/l

0.77

355

1695

Cholecystectomy

2103

13876

1.36

36.80

10.0

8.8

24.30

24.36

mmol/l

0.39

1978

12861

Disorders of parathyroid gland

648

3781

1.75

36.68

8.2

7.8

24.12

24.46

mmol/l

1.64

606

3501

Left bundle-branch block

237

982

2.54

36.63

9.0

8.2

23.95

24.22

mmol/l

0.55

221

926

Injury of unspecified body region

276

1226

2.38

36.62

12.2

9.7

24.33

24.28

mmol/l

0.09

263

1149

Hydronephrosis

372

1852

2.10

36.60

9.4

8.5

23.31

24.50

mmol/l

7.66

351

1714

Hyperkinetic disorders, excluding more controls

192

690

2.78

36.59

11.1

12.1

23.74

23.99

mmol/l

0.51

179

672

Sequelae of other external causes

205

799

2.74

36.30

12.1

10.1

24.05

24.36

mmol/l

0.62

196

751

Hepatic failure, not elsewhere classified

163

568

3.14

36.15

20.9

11.1

23.31

24.51

mmol/l

3.35

154

530

Coxarthrosis

1664

8099

1.42

35.96

8.3

9.8

24.39

24.37

mmol/l

0.09

1548

7535

Dental caries 3 and operation codes

2946

11720

1.30

35.76

9.4

9.3

24.25

24.30

mmol/l

0.35

2774

10875

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

157

5.83

35.61

9.5

9.7

22.96

24.79

mmol/l

7.25

144

Diabetic retinopathy, excluding more controls

874

3094

1.64

35.47

13.1

11.0

23.68

24.16

mmol/l

3.14

802

2864

Postprocedural endocrine and metabolic disorders, not elsewhere classified

326

1560

2.16

35.38

9.6

8.4

24.51

24.35

mmol/l

0.43

306

1453

Acute upper respiratory infections

3160

15575

1.28

35.38

9.7

9.3

24.47

24.26

mmol/l

3.08

2915

14552

Transient ischemic attack

1662

9971

1.41

35.34

8.8

8.5

24.27

24.38

mmol/l

0.69

1532

9224

Unspecified mental disorder

1133

7686

1.50

35.00

9.1

10.0

24.70

24.21

mmol/l

4.93

1011

7228

Toxic effects of substances chiefly nonmedicinal as to source

361

1806

2.08

34.97

10.9

10.1

24.13

24.24

mmol/l

0.27

329

1706

Speech and linguistic disorders, excluding more controls

204

749

2.65

34.96

11.0

11.3

23.96

24.17

mmol/l

0.41

193

714

Benign neoplasm: Rectum

604

3561

1.76

34.92

8.8

9.1

24.36

24.30

mmol/l

0.16

555

3314

In situ neoplasms

1060

7115

1.52

34.86

8.2

8.0

24.30

24.34

mmol/l

0.17

1012

6578

Disorders of eyelid, lacrimal system and orbit

2530

15284

1.31

34.82

7.7

9.4

24.56

24.29

mmol/l

4.21

2321

14263

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

733

4536

1.66

34.74

11.0

9.8

24.23

24.35

mmol/l

0.38

660

4289

Ptosis of eyelid

386

1990

2.04

34.72

8.9

9.0

24.70

24.35

mmol/l

1.41

357

1855

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

124

377

3.64

34.70

10.9

8.4

25.09

24.65

mmol/l

1.09

117

350

Other disorders of the musculoskeletal system and connective tissue

478

2638

1.88

34.60

8.6

9.5

24.45

24.30

mmol/l

0.54

449

2465

Other specified and unspecified disorders of eye and adnexa

160

564

3.06

34.53

8.5

9.7

24.36

24.33

mmol/l

0.03

148

526

L04AX Other immunosuppressants

1561

11271

1.41

34.27

11.5

9.4

24.39

24.31

mmol/l

0.41

1441

10568

Nonalcoholic fatty liver disease

303

1435

2.21

34.19

11.5

10.4

24.30

24.33

mmol/l

0.06

284

1354

Other diseases of lip and oral mucosa

494

2762

1.85

34.04

9.9

9.0

24.52

24.40

mmol/l

0.39

461

2575

Diseases of the musculoskeletal system and connective tissue

1659

5954

1.41

34.00

9.9

10.7

24.18

mmol/l

0.01

1554

5612

Schizophrenia or delusion

882

5722

1.57

33.85

8.9

10.2

24.84

24.20

mmol/l

5.93

779

5380

Phobic anxiety disorders

312

1490

2.15

33.78

10.7

10.1

24.26

24.08

mmol/l

0.47

291

1420

Fentanyl

318

1537

2.15

33.75

9.5

8.3

25.26

24.34

mmol/l

4.27

297

1397

ILD medications: nintedanib

7.74

33.73

13.3

10.9

25.19

24.43

mmol/l

1.00

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1378

6660

1.45

33.69

7.8

9.1

24.24

24.48

mmol/l

2.01

1273

6039

Viral pneumonia (known virus, not influenza)

113

331

3.80

33.57

9.5

10.1

24.68

24.37

mmol/l

0.39

105

307

Other diseases of arteries and capillaries

312

1507

2.17

33.49

10.0

8.4

24.27

24.31

mmol/l

0.07

285

1401

Injury of other and unspecified intrathoracic organs

244

1071

2.42

33.45

11.6

10.4

24.07

24.35

mmol/l

0.60

229

1005

Coxarthrosis [arthrosis of hip](FG)

1764

9374

1.38

33.43

8.5

9.2

24.42

24.33

mmol/l

0.56

1646

8717

Certain disorders involving the immune mechanism

593

3516

1.74

33.28

13.7

9.6

24.17

24.29

mmol/l

0.39

551

3294

Schizophrenia, schizotypal and delusional disorders

882

5746

1.57

33.22

8.9

10.2

24.83

24.21

mmol/l

5.73

781

5401

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1357

6576

1.45

33.20

7.9

9.0

24.26

24.49

mmol/l

1.77

1259

5964

Diplopia

421

2262

1.94

33.19

10.7

9.1

24.67

24.26

mmol/l

1.74

395

2121

Benign neoplasm: Ascending colon

459

2543

1.89

33.12

7.9

8.8

24.29

24.28

mmol/l

0.02

412

2371

Second line medication for Crohn's disease

1585

11541

1.39

33.06

11.5

9.5

24.37

24.32

mmol/l

0.29

1465

10821

Disorders of calcium metabolism

212

877

2.56

33.06

9.6

8.1

23.82

24.50

mmol/l

1.61

198

819

Other diseases of pancreas

282

1325

2.25

32.80

14.0

9.5

23.68

24.34

mmol/l

2.40

268

1238

Abnormal serum enzyme levels

1048

7030

1.51

32.79

9.6

9.9

23.95

24.24

mmol/l

2.40

996

6525

Osteonecrosis

224

957

2.50

32.79

11.8

9.7

24.57

24.41

mmol/l

0.31

210

904

Benign neoplasm of mouth and pharynx

318

1560

2.12

32.53

8.2

9.4

24.69

24.34

mmol/l

1.23

300

1432

Carcinoma in situ of skin of other and unspecified parts of face

264

1211

2.30

32.51

6.2

7.0

24.35

24.52

mmol/l

0.36

250

1076

Adverse effects, not elsewhere classified

533

3084

1.77

32.47

10.8

9.5

24.31

24.22

mmol/l

0.24

511

2904

Stomatitis and related lesions

262

1195

2.29

32.36

10.5

9.5

24.10

24.30

mmol/l

0.41

248

1118

Other disorders of eye and adnexa

408

2184

1.93

32.36

8.8

9.4

24.36

24.29

mmol/l

0.17

376

2052

Open wound of forearm

307

1497

2.14

32.07

7.8

9.7

24.47

24.24

mmol/l

0.66

286

1406

Vitreous haemorrhage

353

1815

2.04

31.99

12.2

9.2

23.67

24.26

mmol/l

2.66

323

1694

DVT of lower extremities

611

3692

1.71

31.99

8.4

9.0

24.29

mmol/l

0.01

573

3439

Nephrotic syndrome

140

480

3.18

31.97

11.7

12.4

23.32

24.51

mmol/l

3.55

134

457

Dental caries 3, only avohilmo

2741

10935

1.30

31.83

8.4

9.6

24.30

24.29

mmol/l

0.05

2555

10173

Traumatic subarachnoid haemorrhage

147

518

3.06

31.78

12.9

10.0

23.89

24.40

mmol/l

0.87

140

481

Other/unspecified cytomegaloviral diseases

258

4.14

31.67

15.8

14.5

23.19

24.43

mmol/l

4.03

246

Myalgia

621

3767

1.69

31.67

10.0

9.5

24.43

24.37

mmol/l

0.21

590

3546

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

333

1684

2.07

31.64

12.6

9.7

24.33

24.30

mmol/l

0.05

319

1583

Cytomegalovirus infection, IBD co-morbidity

106

310

3.80

31.59

14.8

13.5

23.30

24.38

mmol/l

3.48

292

Other maltreatment syndromes

122

387

3.38

31.50

10.3

10.9

23.78

24.34

mmol/l

0.85

117

372

Candidiasis

396

2120

1.93

31.45

15.7

9.2

24.15

24.30

mmol/l

0.33

360

1988

Noninfective enteritis and colitis

1312

9338

1.43

31.22

10.5

9.6

24.11

24.27

mmol/l

1.04

1217

8717

Open wound of ankle and foot

326

1644

2.06

31.01

9.1

10.7

24.30

24.24

mmol/l

0.13

305

1549

Benign neoplasm: Adrenal gland

274

1304

2.23

30.93

8.3

9.8

24.23

24.33

mmol/l

0.18

261

1226

Dental caries 1, only avohilmo

2621

10437

1.30

30.92

8.7

9.6

24.30

24.29

mmol/l

0.07

2442

9714

Pneumonia derived septicemia

137

472

3.13

30.85

9.9

11.0

24.64

24.32

mmol/l

0.44

126

437

Abnormal involuntary movements

423

2331

1.88

30.79

7.4

9.1

24.23

24.26

mmol/l

0.06

384

2173

Charcot foot

213

4.41

30.71

12.8

12.0

23.85

24.54

mmol/l

0.70

201

Other and unspecified injuries of head

215

929

2.44

30.48

9.4

9.7

24.38

mmol/l

0.01

204

869

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

970

4225

1.52

30.47

6.8

8.5

24.57

24.64

mmol/l

0.31

906

3885

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

970

4226

1.52

30.44

6.8

8.5

24.57

24.64

mmol/l

0.31

906

3886

Umbilical hernia

831

5462

1.56

30.41

10.3

9.9

24.30

24.23

mmol/l

0.24

768

5116

Deforming dorsopathies

793

5154

1.57

30.33

8.0

9.4

24.56

24.26

mmol/l

1.76

741

4858

Injuries to the elbow and forearm

1916

13124

1.34

30.25

9.5

9.4

24.31

24.34

mmol/l

0.13

1789

12257

Familial hypercholesterolemia

498

2897

1.78

30.10

8.5

8.3

24.28

24.35

mmol/l

0.18

458

2667

Right hemicolectomy

233

1053

2.36

30.00

13.3

8.6

23.82

24.37

mmol/l

1.83

226

978

Event of undetermined intent

204

866

2.48

29.99

8.5

11.3

24.18

24.39

mmol/l

0.47

196

825

Lumbar disc prolapse

1880

11286

1.34

29.93

10.4

10.1

24.40

24.28

mmol/l

0.90

1742

10625

Cholera

168

655

2.75

29.93

8.1

8.8

24.43

24.67

mmol/l

0.46

163

608

Other arterial embolism and thrombosis

127

429

3.22

29.77

15.9

7.9

24.35

24.71

mmol/l

0.46

114

396

Cytomegaloviral disease

107

328

3.60

29.62

14.6

12.6

23.32

24.34

mmol/l

3.25

100

311

Gonarthrosis [arthrosis of knee](FG)

2385

10902

1.30

29.57

8.1

9.7

24.38

24.33

mmol/l

0.31

2194

10173

Malignant neoplasm of colon

498

2919

1.77

29.49

8.2

23.81

24.28

mmol/l

2.62

484

2689

Abnormal spermatozoa

2734

0.30

29.40

7.1

10.4

24.53

24.18

mmol/l

0.52

2540

Chronic ulcer of skin, not elsewhere classified

253

1190

2.25

29.38

7.7

9.3

24.84

24.37

mmol/l

1.25

228

1107

Scoliosis

242

1111

2.26

29.34

7.8

8.4

24.84

24.30

mmol/l

1.72

229

1044

Other and unspecified coagulation defects

165

643

2.72

29.22

12.8

10.5

24.01

24.30

mmol/l

0.53

158

603

Eating disorder

185

754

2.52

29.16

8.7

9.6

24.40

23.87

mmol/l

1.10

170

720

Conjunctivitis

1943

12912

1.33

29.15

8.9

9.8

24.37

24.32

mmol/l

0.27

1821

12123

Hyperparathyroidism

549

3266

1.71

29.12

8.1

7.8

23.98

24.47

mmol/l

2.68

514

3021

Assault by bodily force

218

963

2.35

29.05

11.3

10.8

23.83

24.24

mmol/l

0.96

204

914

Neuromuscular dysfunction of bladder

300

1506

2.08

29.04

9.1

9.7

24.28

24.27

mmol/l

0.03

279

1413

Adenocarcinoma and Papillary adenocarcinoma of kidney

186

4.87

29.02

9.5

12.7

22.96

24.62

mmol/l

7.34

175

Benign neoplasm: Caecum

360

1932

1.96

28.90

9.7

8.8

24.17

24.31

mmol/l

0.39

333

1801

Benign neoplasm: Transverse colon

361

1944

1.95

28.70

8.1

9.1

24.25

24.28

mmol/l

0.05

330

1818

Malignant neoplasm of bladder

283

1403

2.13

28.64

10.4

8.3

23.43

24.21

mmol/l

4.04

267

1284

Fracture of foot, except ankle

645

4054

1.63

28.59

9.2

10.1

24.25

24.21

mmol/l

0.09

610

3810

Other coagulation defects

228

1037

2.30

28.54

12.5

10.1

24.06

24.26

mmol/l

0.39

216

977

Sequelae of injuries of lower limb

297

1502

2.06

28.08

10.4

10.1

24.13

24.33

mmol/l

0.54

281

1418

Diseases of peritoneum

335

1769

1.97

28.01

12.3

9.5

23.62

24.30

mmol/l

2.90

315

1643

Arthropathies

2675

10753

1.28

27.99

9.1

10.4

24.09

24.29

mmol/l

2.47

2484

10074

Myocardial infarction, with ST-elevation

609

3823

1.64

27.58

10.7

9.0

23.82

24.31

mmol/l

3.31

555

3502

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1011

4241

1.49

27.58

8.8

10.8

23.80

24.26

mmol/l

4.90

958

3855

Acute peritonitis

235

1102

2.25

27.52

15.2

10.0

23.27

24.26

mmol/l

4.02

223

1028

Sleep disorders

560

3433

1.67

27.51

9.2

9.9

24.38

24.22

mmol/l

0.60

509

3224

Status epilepticus

144

543

2.84

27.43

8.1

10.8

23.76

24.26

mmol/l

0.90

136

508

Viral infections characterized by skin and mucous membrane lesions

1151

8203

1.43

27.41

10.6

9.7

24.29

24.30

mmol/l

0.06

1064

7681

Focal brain injury

223

1022

2.28

27.36

11.2

9.9

24.07

24.35

mmol/l

0.55

208

950

Other diseases of stomach and duodenum

227

1052

2.27

27.32

9.5

9.0

23.93

24.36

mmol/l

1.07

213

977

Purpura and other haemorrhagic conditions

412

2337

1.82

27.28

10.5

9.3

23.82

24.26

mmol/l

2.09

393

2180

Somnolence, stupor and coma

166

673

2.62

27.20

8.6

9.9

24.48

24.24

mmol/l

0.36

154

629

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

374

1858

1.86

27.07

12.9

11.7

23.92

23.90

mmol/l

0.04

353

1776

Personal history of other diseases and conditions

257

1238

2.12

27.07

11.2

8.9

24.13

24.21

mmol/l

0.14

242

1187

Chronic rhinitis, nasopharyngitis and pharyngitis

867

5888

1.50

26.91

9.4

9.5

24.33

24.24

mmol/l

0.37

823

5533

Malignant neoplasm of head and neck

300

1555

2.03

26.75

11.5

9.7

25.04

24.25

mmol/l

4.58

284

1443

Other symptoms and signs involving the urinary system

342

1849

1.93

26.64

9.4

10.1

24.42

24.21

mmol/l

0.58

299

1727

Symptoms and signs involving the nervous and musculoskeletal systems

1636

12378

1.34

26.63

9.4

9.1

24.26

24.31

mmol/l

0.24

1514

11536

Hypopituitarism

222

1028

2.26

26.61

7.1

11.6

24.18

24.28

mmol/l

0.21

208

980

Other systemic involvement of connective tissue (FG)

712

4623

1.56

26.60

9.2

8.4

24.45

24.33

mmol/l

0.46

658

4299

Hypertrophic cardiomyopathy

168

696

2.60

26.59

17.8

10.8

23.96

24.34

mmol/l

0.76

159

661

Disorders of continuity of bone

279

1407

2.06

26.58

9.8

24.25

24.32

mmol/l

0.14

264

1329

Noninfectious colitis NAS

399

2257

1.82

26.57

9.4

9.1

24.40

24.28

mmol/l

0.27

375

2100

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1314

9449

1.38

26.57

9.2

9.4

24.28

24.32

mmol/l

0.19

1229

8887

Other joint disorders

2543

10714

1.28

26.56

8.4

10.3

24.11

24.29

mmol/l

2.03

2376

10037

Tobacco use

177

748

2.50

26.47

10.0

11.3

24.45

24.28

mmol/l

0.21

163

714

Abscess of anal and rectal regions

267

1328

2.09

26.45

10.8

10.1

23.86

24.22

mmol/l

1.01

245

1244

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

170

709

2.55

26.32

8.4

7.7

24.34

24.38

mmol/l

0.05

163

641

Pneumonia due to Streptococcus pneumoniae

144

553

2.75

26.28

10.3

9.7

24.42

23.91

mmol/l

0.78

133

518

Colon adenocarcinoma

408

2340

1.82

26.26

8.3

8.1

23.84

24.27

mmol/l

2.05

396

2153

Sulfonylureas

1187

6821

1.42

26.20

9.4

7.8

23.82

24.43

mmol/l

5.77

1071

6305

Acute posthaemorrhagic anaemia

142

546

2.79

26.10

10.0

9.6

23.57

24.53

mmol/l

2.06

128

503

Hemiplegia

188

821

2.42

26.10

10.5

9.8

24.71

24.33

mmol/l

0.83

176

767

Covid-19 suspected case

503

3042

1.69

26.00

10.5

9.1

24.47

24.19

mmol/l

1.14

479

2852

Arthrosis

2217

9525

1.29

25.87

8.4

10.1

24.26

24.36

mmol/l

0.74

2028

8904

Cholecystitis

448

2650

1.75

25.58

8.7

8.3

24.19

24.34

mmol/l

0.46

417

2425

Filling of root of tooth

120

428

3.02

25.48

11.6

10.5

23.93

24.35

mmol/l

0.72

115

406

Arthropathies in other diseases classified elsewhere

139

535

2.78

25.46

10.8

11.5

24.03

24.38

mmol/l

0.44

123

504

Voice disturbances

729

4842

1.54

25.43

10.3

8.9

24.37

24.33

mmol/l

0.12

669

4523

Allergic conjunctivitis

1363

9942

1.37

25.39

9.1

9.4

24.30

24.32

mmol/l

0.12

1275

9349

Benign neoplasm: Descending colon

212

985

2.27

25.38

7.2

8.6

23.98

24.35

mmol/l

0.88

196

905

Disorders of conjunctiva

2176

14356

1.28

25.33

9.2

9.7

24.38

24.30

mmol/l

0.56

2036

13454

Insomnia

418

2432

1.76

25.13

8.9

9.7

24.35

24.26

mmol/l

0.23

379

2291

Benign neoplasm: Stomach

273

1395

2.03

25.12

10.6

8.7

24.64

24.43

mmol/l

0.45

251

1278

Carcinoma in situ of skin

242

1190

2.13

24.96

6.9

7.3

24.33

24.41

mmol/l

0.14

227

1073

Dermatitis

1698

13036

1.32

24.94

9.9

9.2

24.24

24.31

mmol/l

0.42

1540

12196

Cholangitis (primary sclerosing, PSC)

214

1006

2.24

24.90

13.9

9.6

23.68

24.37

mmol/l

2.23

205

930

Gonarthrosis

2028

9049

1.30

24.84

8.0

10.1

24.33

24.37

mmol/l

0.22

1866

8451

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

128

477

2.83

24.78

14.9

11.0

23.73

24.38

mmol/l

1.43

119

457

Shoulder lesions

2322

11264

1.28

24.78

8.2

9.7

24.38

24.34

mmol/l

0.28

2132

10530

Congenital malformations of pulmonary and tricuspid valves

7.13

24.73

23.2

18.8

24.75

24.25

mmol/l

0.42

Melanocytic naevi

646

4200

1.56

24.65

8.5

9.5

24.24

24.30

mmol/l

0.18

600

3881

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

595

3755

1.59

24.52

12.5

9.7

23.93

24.10

mmol/l

0.61

553

3548

Dissection of aorta

134

518

2.79

24.49

21.3

7.8

24.41

24.43

mmol/l

0.03

126

480

Infection of intervertebral disc (pyogenic)

185

4.32

24.47

11.9

11.6

24.19

24.67

mmol/l

0.54

173

Complex cardiac defects

7.58

24.33

40.6

12.5

24.48

24.45

mmol/l

0.02

Pneumococcal septicemia

130

496

2.81

24.32

9.8

11.5

24.63

24.49

mmol/l

0.15

119

465

Other eating disorders

116

412

2.91

24.28

9.4

10.1

24.23

23.84

mmol/l

0.49

108

396

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

852

5867

1.47

24.28

10.0

10.5

24.36

24.18

mmol/l

1.00

798

5528

Type 1 diabetes, definitions combined

243

1200

2.07

24.12

14.4

9.7

23.10

24.25

mmol/l

4.22

229

1154

Nonorganic sleeping disorders

478

2913

1.68

24.12

9.6

9.9

24.29

24.23

mmol/l

0.16

436

2733

Speech disturbances, not elsewhere classified

288

1525

1.97

24.04

8.9

8.8

24.68

24.31

mmol/l

1.14

273

1414

Erosion of teeth, including avohilmo

453

2627

1.70

23.97

12.5

9.4

24.59

24.33

mmol/l

0.92

436

2464

General examination and investigation of persons without complaint and reported diagnosis

1825

7468

1.31

23.92

10.2

9.7

24.26

24.36

mmol/l

0.72

1618

7018

Seropositive rheumatoid arthritis

715

4779

1.52

23.88

8.6

8.8

24.63

24.38

mmol/l

1.27

661

4449

Dipeptidyl peptidase 4 (DPP-4) inhibitors

386

2240

1.79

23.85

11.4

8.7

24.29

24.45

mmol/l

0.36

350

2095

Dementia in Alzheimer disease

171

3151

0.45

23.84

4.5

6.8

23.97

24.36

mmol/l

0.60

136

2862

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

377

2171

1.79

23.72

9.3

9.2

24.25

24.44

mmol/l

0.53

354

1986

Embolic stroke

181

812

2.36

23.69

9.0

8.1

24.80

24.44

mmol/l

0.69

169

733

Acetic acid derivatives and related substances

934

3364

1.47

23.68

8.1

10.0

24.16

24.14

mmol/l

0.04

868

3120

Primary_lymphoid and hematopoietic malignant neoplasms

736

4980

1.51

23.66

10.1

8.9

24.20

24.31

mmol/l

0.37

685

4611

Disorders of psychological development

262

1237

2.01

23.66

11.7

12.2

24.05

24.06

mmol/l

0.01

246

1177

Other diseases of upper respiratory tract

3429

14799

1.22

23.62

9.7

9.6

24.35

24.26

mmol/l

0.94

3207

13780

Migraine with aura

493

3040

1.65

23.51

8.9

9.4

24.24

24.18

mmol/l

0.17

461

2856

Other viral diseases

716

4798

1.51

23.43

14.0

10.3

24.24

24.18

mmol/l

0.18

671

4515

Biomechanical lesions, not elsewhere classified

170

747

2.41

23.42

6.5

10.1

24.14

24.43

mmol/l

0.74

160

703

Zoster [herpes zoster]

519

3261

1.64

23.39

9.3

8.5

24.47

24.36

mmol/l

0.31

477

3027

Abscess of lung

224

3.85

23.33

7.6

10.3

24.87

24.72

mmol/l

0.11

212

Open wound of abdomen, lower back and pelvis

113

409

2.95

23.30

8.6

11.2

24.01

24.48

mmol/l

0.67

108

387

Other disorders involving the immune mechanism, not elsewhere classified

123

467

2.83

23.27

11.1

12.1

22.99

24.46

mmol/l

5.71

118

447

Other or ill-defined heart diseases

157

665

2.46

23.19

14.5

9.1

24.31

24.14

mmol/l

0.27

147

622

Other and unspecified dermatitis

1383

10433

1.34

23.14

10.1

9.1

24.28

24.29

mmol/l

0.07

1257

9761

Paracetamol of NSAID medication

523

1603

1.67

23.06

10.1

11.2

24.29

24.15

mmol/l

0.43

492

1492

Diabetic neuropathy

422

2529

1.74

23.01

11.0

11.5

23.76

23.96

mmol/l

0.47

380

2310

Other problems related to primary support group, including family circumstances

264

1334

1.98

22.94

16.0

10.3

23.78

24.10

mmol/l

0.91

247

1271

Other arthritis (FG)

849

5932

1.46

22.83

11.3

9.6

24.37

24.27

mmol/l

0.42

801

5564

Follow-up examination after treatment for malignant neoplasms

330

1851

1.84

22.79

8.8

8.3

23.96

24.45

mmol/l

1.74

315

1728

Eating disorders

228

1125

2.07

22.78

8.3

9.7

24.57

24.04

mmol/l

1.37

210

1065

Tubulo-interstitial nephritis, not specified as acute or chronic

213

1032

2.15

22.75

10.1

7.8

24.26

24.53

mmol/l

0.53

197

943

Superficial injury of hip and thigh

413

2465

1.72

22.72

7.8

8.4

24.77

24.27

mmol/l

2.09

378

2272

Malignant neoplasm of oral cavity

139

569

2.64

22.67

9.9

10.0

24.96

24.61

mmol/l

0.88

130

532

Paralytic ileus

146

610

2.55

22.60

13.6

8.2

23.88

24.32

mmol/l

0.72

139

566

Other disorders of skin and subcutaneous tissue, not elsewhere classified

423

2550

1.71

22.53

7.6

8.7

24.62

24.30

mmol/l

1.10

378

2377

Type 1 diabetes, strict (exclude DM2)

239

1205

2.03

22.43

14.5

10.5

23.05

24.28

mmol/l

4.62

225

1162

Fall on same level involving ice and snow

1547

11907

1.32

22.40

9.6

9.2

24.32

mmol/l

0.02

1460

11115

Other necrotizing vasculopathies (FG)

201

962

2.19

22.36

10.8

9.5

24.44

24.34

mmol/l

0.18

185

904

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1474

11036

1.32

22.33

11.4

10.0

24.51

24.25

mmol/l

2.99

1379

10351

Trochanteric bursitis

377

2211

1.75

22.20

7.9

8.5

24.44

24.50

mmol/l

0.13

345

2069

Postprocedural disorders of digestive system, not elsewhere classified

125

490

2.74

22.19

11.6

10.5

23.91

24.58

mmol/l

1.18

119

463

Other necrotizing vasculopathies

241

1238

2.04

22.13

11.1

9.3

24.45

24.37

mmol/l

0.15

223

1156

Other disorders of adrenal gland

145

608

2.52

22.13

11.9

10.5

23.84

24.33

mmol/l

0.99

139

577

Disorders of skin appendages

1196

8884

1.36

22.10

10.1

9.7

24.13

24.25

mmol/l

0.69

1114

8345

Malignant melanoma, excluding all cancers (controls excluding all cancers)

459

2838

1.66

22.07

7.8

9.1

24.41

24.50

mmol/l

0.26

435

2587

Other symptoms and signs involving the circulatory and respiratory systems

186

865

2.23

22.05

9.2

9.8

24.89

24.15

mmol/l

2.43

166

814

Other blood glucose lowering drugs, excl. Insulins

514

3271

1.62

22.03

10.5

8.4

24.29

24.49

mmol/l

0.68

470

3045

L01XE Protein kinase inhibitors

208

1019

2.16

21.97

8.0

9.5

24.34

mmol/l

0.00

196

957

170

759

2.29

21.96

9.4

7.8

23.74

23.86

mmol/l

0.19

165

722

Cramp and spasm

159

700

2.40

21.80

6.5

11.8

24.32

24.33

mmol/l

0.01

148

663

Melanocytic naevi of trunk

285

1546

1.90

21.79

9.2

9.4

24.32

24.26

mmol/l

0.10

272

1431

Inflammatory diseases of the central nervous system

253

1327

1.98

21.67

10.0

10.5

24.40

24.32

mmol/l

0.14

234

1246

Complications of cardiac and vascular prosthetic devices, implants and grafts

307

3.25

21.61

17.9

9.9

24.09

24.63

mmol/l

0.91

283

Other orthopaedic follow-up care

180

837

2.25

21.50

7.1

10.4

24.66

24.51

mmol/l

0.29

170

782

Duodenal ulcer

367

2164

1.75

21.38

11.9

8.4

23.72

24.27

mmol/l

1.99

322

1977

Kela-code for severe mental illness

966

6983

1.40

21.34

8.6

10.1

24.75

24.22

mmol/l

4.76

854

6559

Bulimia nervosa (incl. atypical)

253

3.33

21.28

8.2

9.7

24.04

23.59

mmol/l

0.55

239

Benign neoplasm of middle ear and respiratory system

233

1197

2.02

21.23

9.7

9.5

24.75

24.32

mmol/l

1.35

221

1093

Superficial injury of thorax

425

2606

1.67

21.17

10.8

9.4

24.26

24.29

mmol/l

0.07

388

2422

Disorders of muscles

302

1688

1.85

21.11

11.2

10.1

24.26

24.35

mmol/l

0.16

280

1583

Right bundle-branch block

122

483

2.67

21.09

15.4

8.1

24.37

24.39

mmol/l

0.02

115

456

Migraine

1017

6288

1.39

21.03

9.2

10.0

24.25

24.23

mmol/l

0.06

947

5908

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

224

3.64

21.00

10.8

9.6

24.61

24.79

mmol/l

0.19

204

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

956

4103

1.42

21.00

8.3

10.8

23.78

24.25

mmol/l

4.92

904

3724

Toxic effect of ethanol

135

563

2.52

20.83

12.5

12.3

23.74

24.38

mmol/l

1.45

126

538

Localized swelling, mass and lump of skin and subcutaneous tissue

859

6128

1.43

20.68

9.1

9.5

24.36

24.32

mmol/l

0.16

797

5725

Benign neoplasm: Small intestine

135

568

2.53

20.61

7.5

7.6

24.39

24.47

mmol/l

0.12

125

519

Injuries to the wrist and hand

2760

16523

1.22

20.55

10.2

9.7

24.35

24.28

mmol/l

0.57

2582

15448

!Aliquae complicationes praecoces traumatis

145

630

2.43

20.52

7.1

11.2

24.53

24.56

mmol/l

0.03

139

594

Early complications of trauma

145

630

2.43

20.52

7.1

11.2

24.53

24.56

mmol/l

0.03

139

594

Speech and linguistic disorders

206

979

2.07

20.42

13.6

12.3

23.95

24.01

mmol/l

0.11

195

927

Immunodeficiency with predominantly antibody defects

337

3.02

20.42

15.7

10.4

24.25

24.44

mmol/l

0.22

317

Chronic sinusitis

1144

8550

1.36

20.39

9.2

9.5

24.37

24.26

mmol/l

0.54

1064

8002

Fracture of neck

205

1026

2.10

20.38

12.9

9.4

24.71

24.32

mmol/l

0.80

194

958

Anaemia in chronic diseases classified elsewhere

101

373

2.94

20.34

11.6

11.9

22.59

24.56

mmol/l

7.53

351

Post-traumatic stress disorder

163

741

2.25

20.25

9.8

10.0

23.78

24.04

mmol/l

0.50

149

705

Benign neoplasm: Parotid gland

219

1120

2.03

20.23

12.2

9.5

24.49

24.31

mmol/l

0.34

203

1034

Other disorders of eyelid

1287

9475

1.33

20.20

7.4

8.6

24.64

24.34

mmol/l

2.89

1177

8790

Thyrotoxicosis

637

4320

1.50

20.14

9.7

8.7

24.60

24.35

mmol/l

1.18

602

4039

Amputation of thigh

118

475

2.67

19.94

13.3

8.1

24.69

24.46

mmol/l

0.27

106

432

Other specified/unspecified arthritis

725

5050

1.46

19.92

11.3

9.9

24.41

24.34

mmol/l

0.20

682

4734

Visual field defects

267

1469

1.89

19.84

9.0

9.4

23.90

24.33

mmol/l

1.30

255

1376

Arterial embolism and thrombosis of lower extremity artery

134

573

2.49

19.76

11.9

8.0

23.58

24.45

mmol/l

2.15

122

535

Other systemic involvement of connective tissue

733

5142

1.45

19.45

9.1

8.2

24.42

24.37

mmol/l

0.15

677

4792

Dermatitis and eczema

3105

17074

1.20

19.38

9.8

9.6

24.35

24.28

mmol/l

0.49

2857

15976

Coxibs

891

3380

1.42

19.37

8.4

10.0

24.29

24.14

mmol/l

0.72

829

3136

Social phobias

174

827

2.16

19.36

11.0

10.3

24.15

24.13

mmol/l

0.04

166

793

Exposure to other and unspecified inanimate mechanical forces

198

993

2.07

19.35

9.0

11.0

24.42

24.33

mmol/l

0.17

191

942

Disorders of oesophagus in diseases classified elsewhere

283

3.19

19.31

9.6

10.7

24.57

24.78

mmol/l

0.16

267

Injuries to the neck

575

3854

1.52

19.27

10.3

9.6

24.37

24.23

mmol/l

0.45

538

3611

Pulmonary oedema

263

3.28

19.17

11.9

9.0

24.62

24.68

mmol/l

0.04

241

Osteoporosis with pathological fracture (FG)

198

998

2.07

19.17

8.6

6.9

25.24

24.43

mmol/l

1.59

185

928

Acute sinusitis

1287

9190

1.32

19.12

9.3

9.7

24.39

24.23

mmol/l

1.07

1187

8643

Symptoms and signs involving emotional state

354

2.86

19.09

9.0

9.3

24.20

24.38

mmol/l

0.20

335

Special screening examination for neoplasms

159

741

2.25

19.03

9.7

9.4

24.23

24.29

mmol/l

0.08

148

695

Chronic laryngitis and laryngotracheitis

410

2562

1.64

19.03

8.7

8.8

24.50

24.21

mmol/l

1.22

378

2391

Thrombocytopenia, unspecified

225

1190

1.97

18.99

11.1

10.0

23.96

24.24

mmol/l

0.73

214

1112

Rheumatoid arthritis

895

5921

1.39

18.87

8.6

9.5

24.63

24.39

mmol/l

1.46

830

5514

Opening and dilatation of root channel of tooth

179

873

2.13

18.87

11.6

10.6

23.88

24.32

mmol/l

1.09

171

831

Reimbursement for rheumatic diseases

1554

12212

1.28

18.85

10.2

9.0

24.49

24.34

mmol/l

1.11

1445

11408

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

380

2336

1.67

18.81

7.8

9.0

24.40

24.42

mmol/l

0.05

359

2129

Functional dyspepsia

681

4741

1.46

18.80

10.3

8.5

24.48

24.32

mmol/l

0.66

635

4422

Benign neoplasm of major salivary glands

258

1426

1.87

18.77

11.1

8.8

24.50

24.35

mmol/l

0.30

239

1299

Amputation of ankle bones

350

2.92

18.69

14.4

10.1

24.46

24.58

mmol/l

0.12

322

Carcinoma in situ of skin of other and unspecified parts of face

264

1480

1.87

18.65

6.2

7.1

24.35

24.37

mmol/l

0.02

250

1350

Barrett oesophagus

168

809

2.19

18.61

11.2

10.9

24.13

24.37

mmol/l

0.43

162

759

Thyrotoxicosis, other and/or unspecified

501

3290

1.55

18.57

10.3

8.8

24.52

24.31

mmol/l

0.82

471

3081

Appendectomy

1662

12724

1.27

18.51

10.6

9.7

24.17

24.31

mmol/l

1.10

1552

11940

Irritable bowel syndrome

637

4396

1.47

18.35

8.4

8.8

24.43

24.34

mmol/l

0.31

591

4113

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

328

1963

1.74

18.32

9.1

9.0

24.15

24.27

mmol/l

0.30

314

1824

Artrosis, including avohilmo

2536

11488

1.22

18.29

8.3

10.2

24.28

24.26

mmol/l

0.09

2328

10734

Radiculopathy

486

3186

1.56

18.28

6.7

9.1

24.51

24.31

mmol/l

0.81

449

2972

Type 1 diabetes, strict definition, subgroup 1

164

778

2.15

18.25

13.8

8.4

22.85

24.16

mmol/l

3.54

157

751

Weight loss

290

1677

1.79

18.24

8.2

9.3

24.47

24.31

mmol/l

0.27

260

1571

Dronedarone medication

107

429

2.67

18.23

8.7

7.8

24.85

24.36

mmol/l

0.80

100

408

Oesophagitis

178

881

2.11

18.20

13.5

10.3

24.25

24.39

mmol/l

0.22

171

824

Non-follicular lymphoma, hilmo, excluding all cancers

260

1457

1.85

18.16

9.2

8.9

24.37

24.38

mmol/l

0.01

246

1326

Visual impairment including blindness (binocular or monocular)

207

1080

1.99

18.15

8.5

9.3

24.02

24.35

mmol/l

0.73

182

1001

Somatoform disorder

397

2485

1.63

18.15

7.8

9.4

24.73

24.23

mmol/l

2.46

367

2336

Other disorders of nervous system

211

1111

1.98

18.09

7.2

10.2

24.46

24.38

mmol/l

0.14

195

1045

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

209

1094

1.97

18.00

10.2

9.1

24.52

24.38

mmol/l

0.30

198

1008

Other diseases of oesophagus

299

1750

1.77

17.97

9.8

9.1

24.77

24.31

mmol/l

1.18

277

1613

Embolic stroke with flimmer

361

2.80

17.95

6.7

7.5

24.87

24.55

mmol/l

0.33

327

Carbimazole or st.post thyroidectomy, condition for graves disease

502

3324

1.54

17.91

10.1

8.8

24.61

24.31

mmol/l

1.29

469

3120

Adenocarcinoma and papilloma adenocarcinoma of rectum

315

1877

1.74

17.90

9.0

9.1

24.12

24.27

mmol/l

0.40

301

1743

Other diseases of hard tissues of teeth

1687

10021

1.27

17.84

10.8

9.5

24.17

24.31

mmol/l

1.04

1600

9394

Other diseases of jaws

196

1010

2.01

17.74

9.3

9.6

24.40

24.32

mmol/l

0.10

181

947

Other congenital malformations

218

1162

1.93

17.71

13.3

11.0

23.66

24.27

mmol/l

1.77

208

1107

Cyst of kidney

228

1243

1.92

17.65

10.1

9.5

24.05

24.35

mmol/l

0.75

218

1164

Mixed disorders of conduct and emotions, excluding more controls

142

3.88

17.62

14.2

7.4

23.66

23.60

mmol/l

0.04

137

Hyperfunction of pituitary gland

134

599

2.33

17.62

10.3

10.6

24.19

24.33

mmol/l

0.23

128

571

Diffuse brain injury

112

464

2.52

17.53

10.6

11.6

24.32

24.47

mmol/l

0.16

102

436

Orchitis and epididymitis

306

1818

1.74

17.48

11.9

11.2

24.36

24.16

mmol/l

0.45

274

1690

Use of pramipexole

613

4253

1.47

17.47

8.5

8.7

24.59

24.37

mmol/l

0.94

563

3958

Fenamates

471

2058

1.57

17.46

7.7

10.2

24.38

24.18

mmol/l

0.60

441

1917

Agoraphobia

280

2.98

17.41

14.5

10.4

24.45

23.87

mmol/l

0.78

270

Abnormal results of function studies

239

1325

1.86

17.30

12.2

9.6

24.59

24.19

mmol/l

0.93

228

1239

Collagenous colitis

255

1444

1.83

17.24

10.0

9.3

23.96

24.39

mmol/l

1.22

239

1356

Sequelae of injuries of neck and trunk

104

423

2.61

17.14

12.2

11.5

25.12

24.60

mmol/l

0.92

402

Adrenocortical insufficiency

115

490

2.48

17.09

11.4

10.9

23.93

24.27

mmol/l

0.49

109

463

Other benign neoplasms of skin

858

6205

1.37

16.87

7.8

9.0

24.29

24.44

mmol/l

0.79

797

5652

Congenital malformations and deformations of the musculoskeletal system

208

1105

1.92

16.80

10.5

11.7

24.10

24.12

mmol/l

0.03

201

1052

Recurring oral aphthae, including avohilmo

359

2244

1.64

16.68

9.4

9.2

24.34

24.32

mmol/l

0.04

334

2105

Shock, not elsewhere classified

119

4.31

16.52

26.1

8.0

22.32

24.76

mmol/l

3.15

107

Drug-induced hypoglycaemia without coma

232

3.23

16.52

12.7

9.0

24.41

24.61

mmol/l

0.13

216

Benign neoplasm: Spinal meninges

119

4.30

16.51

5.0

5.9

23.93

24.78

mmol/l

1.33

105

Unspecified misadventure during surgical and medical care

174

887

2.06

16.49

11.7

10.1

24.03

24.40

mmol/l

0.64

162

836

Superficial injury of abdomen, lower back and pelvis

375

2372

1.61

16.49

9.6

9.2

24.49

24.18

mmol/l

1.02

350

2217

Urticaria and erythema

864

6405

1.37

16.43

9.0

9.6

24.49

24.27

mmol/l

1.33

807

6014

Other infectious diseases

242

1372

1.83

16.37

11.4

9.4

24.14

24.26

mmol/l

0.19

229

1275

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

331

2039

1.67

16.35

7.9

7.0

24.01

24.45

mmol/l

1.69

302

1812

Other viral diseases, not elsewhere classified

455

3008

1.54

16.19

15.4

10.2

24.41

24.23

mmol/l

0.66

425

2836

Dissocial personality disorder

224

3.23

16.16

14.4

11.7

24.50

24.38

mmol/l

0.10

213

Other inflammatory liver diseases

195

1040

1.95

16.06

13.0

10.4

24.16

24.34

mmol/l

0.26

183

984

Immunodeficiencies

147

711

2.16

16.03

14.5

10.8

24.55

24.33

mmol/l

0.38

133

670

Abnormal findings on examination of urine, without diagnosis

145

699

2.18

16.02

10.9

9.9

23.37

24.43

mmol/l

2.86

133

658

Conjunctivitis (acute, non atopic)

676

4824

1.42

16.00

8.3

9.8

24.53

24.22

mmol/l

1.96

638

4545

Multiple myeloma and malignant plasma cell neoplasms

144

693

2.18

15.98

7.5

8.1

23.68

24.34

mmol/l

1.09

130

630

Type 1 diabetes, strict definition

171

867

2.01

15.94

14.2

8.9

22.96

24.18

mmol/l

3.29

163

838

Other and unspecified visual disturbances

256

1485

1.78

15.92

9.0

9.5

24.34

24.39

mmol/l

0.10

241

1388

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

491

3184

1.51

15.87

7.3

7.4

24.69

24.65

mmol/l

0.11

466

2895

Lesion of ulnar nerve

401

2604

1.58

15.87

11.4

10.4

24.64

24.26

mmol/l

1.73

375

2451

Faecal incontinence

238

1353

1.81

15.86

7.1

7.6

24.44

24.48

mmol/l

0.08

223

1267

Other disorders of white blood cells

173

892

2.03

15.85

11.3

10.1

24.08

24.32

mmol/l

0.40

165

829

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

246

1416

1.80

15.83

8.4

8.3

24.34

24.41

mmol/l

0.11

218

1314

Budesonide

327

2023

1.65

15.78

9.9

9.1

23.85

24.17

mmol/l

0.96

308

1897

Rotator cuff syndrome

1764

10649

1.24

15.75

8.4

9.7

24.39

24.35

mmol/l

0.19

1624

9957

Multiple myeloma, excluding all cancers (controls excluding all cancers)

144

699

2.16

15.63

7.6

8.1

23.65

24.35

mmol/l

1.16

130

632

Abnormal weight loss

264

1556

1.76

15.62

8.7

9.3

24.31

24.33

mmol/l

0.02

236

1457

Heartburn

267

1574

1.74

15.58

9.1

24.71

24.23

mmol/l

2.17

257

1470

Olecranon bursitis

207

1139

1.89

15.57

10.8

11.3

24.55

24.24

mmol/l

0.63

191

1077

Spondylolisthesis/Spondylolysis

489

3323

1.50

15.52

7.2

9.7

24.40

24.28

mmol/l

0.35

459

3127

Fracture at wrist and hand level

871

6522

1.35

15.51

10.1

10.4

24.29

24.22

mmol/l

0.31

826

6120

Other symptoms and signs involving general sensations and perceptions

123

563

2.29

15.48

8.3

9.9

24.69

24.53

mmol/l

0.21

113

522

Sequelae of injuries of head

161

816

2.06

15.46

10.0

11.6

23.84

24.42

mmol/l

0.99

154

773

Chronic nephritic syndrome

139

670

2.18

15.43

13.4

10.5

23.35

24.45

mmol/l

3.65

131

633

Urticaria

683

4929

1.40

15.42

9.2

9.7

24.45

24.24

mmol/l

1.11

636

4631

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

224

1264

1.83

15.41

12.5

8.6

23.97

24.35

mmol/l

1.16

212

1181

Diseases of salivary glands

482

3268

1.50

15.41

11.5

8.9

24.61

24.38

mmol/l

0.82

444

3048

Benign neoplasm: Rectosigmoid junction

128

598

2.25

15.38

7.1

8.3

24.32

24.30

mmol/l

0.02

123

549

Benign neoplasm: Tongue

367

2.63

15.32

7.5

8.8

25.03

24.45

mmol/l

1.03

341

Acute and transient psychotic disorders

300

1832

1.68

15.31

8.8

10.8

25.03

24.27

mmol/l

3.56

272

1730

Respiratory disorders in diseases classified elsewhere

195

3.38

15.30

15.4

9.9

24.76

24.56

mmol/l

0.19

185

Benign neoplasm of mouth and pharynx

318

1976

1.66

15.28

8.2

9.3

24.69

24.37

mmol/l

1.12

300

1845

Familial hypercholesterolemia, with ischemic heart disease

302

1857

1.68

15.24

9.6

8.1

24.21

24.37

mmol/l

0.38

280

1723

Acute suppurative otitis media

523

3366

1.47

15.05

11.6

11.3

23.91

24.14

mmol/l

0.92

489

3193

Blood alcohol or alcohol intoxication level

305

2.77

15.04

14.0

10.9

24.42

24.29

mmol/l

0.15

287

Hypoparathyroidism

118

539

2.31

15.01

8.7

7.8

24.94

24.45

mmol/l

0.67

109

502

Other diseases of blood and blood-forming organs

211

1181

1.86

15.00

10.6

10.0

24.28

24.32

mmol/l

0.06

206

1104

Hyperkinetic disorders

195

1044

1.88

14.93

11.2

12.7

23.73

24.01

mmol/l

0.60

182

1001

Oter anti-inflammatory and antirheumatic agents, non-steroids

745

3000

1.40

14.92

7.9

9.8

24.49

24.18

mmol/l

1.74

677

2771

Methotrexate

368

2374

1.58

14.92

11.2

8.9

24.47

24.15

mmol/l

1.19

339

2219

Supplementary factors related to causes of morbidity and mortality classified elsewhere

771

5710

1.37

14.90

9.3

9.4

24.20

24.27

mmol/l

0.22

720

5330

Degeneration of macula and posterior pole

1367

8992

1.27

14.87

6.9

8.0

24.22

24.41

mmol/l

1.37

1251

8304

Retinal detachments and breaks

1010

7786

1.32

14.86

9.1

8.9

24.12

24.37

mmol/l

1.59

934

7233

Unspecified jaundice

159

816

2.03

14.76

13.8

9.1

23.72

24.28

mmol/l

1.00

147

753

Other disorders of bladder

352

2260

1.60

14.76

9.0

9.7

24.41

24.21

mmol/l

0.47

330

2098

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

298

2.80

14.74

11.5

8.5

25.03

24.31

mmol/l

1.03

270

Other inflammation of eyelid

346

2211

1.60

14.73

7.8

9.5

24.57

24.30

mmol/l

0.76

323

2065

Malignant neoplasm of tongue

323

2.76

14.72

9.3

10.1

24.92

24.59

mmol/l

0.59

305

Diseases of external ear

889

6741

1.34

14.68

7.9

9.4

24.39

24.28

mmol/l

0.52

818

6288

Volvulus

388

2.54

14.60

10.1

8.6

24.49

24.40

mmol/l

0.09

360

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

700

5134

1.39

14.49

8.7

8.6

24.64

24.37

mmol/l

1.43

647

4779

Paraplegia, diplegia of upper limbs

324

2.71

14.49

8.8

10.5

24.66

24.46

mmol/l

0.19

305

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

348

2.64

14.47

11.0

10.1

25.42

24.55

mmol/l

1.69

323

Dissociative [conversion] disorders

388

2.48

14.36

6.9

9.1

24.24

24.13

mmol/l

0.13

367

Viral and other specified intestinal infections

432

2833

1.51

14.33

11.4

10.4

23.77

24.17

mmol/l

1.77

405

2664

Pyogenic arthritis

201

1123

1.85

14.31

8.2

10.0

24.27

24.38

mmol/l

0.17

182

1052

Gingival hyperplasia

105

466

2.37

14.29

12.3

11.2

23.40

24.46

mmol/l

2.39

436

Alcoholic gastritis

230

3.07

14.29

11.7

11.2

23.78

24.41

mmol/l

0.69

220

Malignant neoplasm of skin

1834

11398

1.22

14.24

7.6

8.6

24.23

24.37

mmol/l

1.11

1705

10529

Disturbance of activity and attention

177

934

1.90

14.19

11.8

12.2

23.67

23.98

mmol/l

0.67

164

897

Postprocedural musculoskeletal disorders, not elsewhere classified

212

1210

1.82

14.16

9.6

9.3

24.43

24.35

mmol/l

0.14

199

1134

Coxarthrosis, primary

1740

12435

1.23

14.16

8.4

8.8

24.41

24.35

mmol/l

0.29

1620

11508

Seropositive rheumatoid arthritis, wide

715

5282

1.38

14.14

8.6

24.63

24.37

mmol/l

1.32

661

4913

Lesion of lateral popliteal nerve

155

802

2.02

14.11

11.2

11.3

24.54

24.34

mmol/l

0.29

139

756

Other/unspecified seropositive rheumatoid arthritis

707

5218

1.38

14.07

8.6

24.62

24.37

mmol/l

1.28

654

4853

Acute gastritis

222

1284

1.78

14.04

7.0

9.4

24.36

24.40

mmol/l

0.06

199

1191

Inguinal hernia

1769

9807

1.23

14.00

10.0

9.9

24.28

24.23

mmol/l

0.25

1629

9163

Meniscus derangement

1623

9054

1.24

13.98

8.2

10.3

24.27

24.37

mmol/l

0.68

1525

8483

Dental operations

2100

8971

1.21

13.94

9.4

9.1

24.27

24.30

mmol/l

0.17

1963

8290

Other disorders of lacrimal gland

839

6357

1.34

13.94

7.7

9.0

24.58

24.35

mmol/l

1.30

761

5960

Pure hyperglyceridaemia

289

2.76

13.89

11.0

9.7

24.24

24.42

mmol/l

0.19

272

Strabismus

636

4613

1.40

13.88

11.5

9.8

24.38

24.22

mmol/l

0.62

590

4331

Prurigo nodularis

374

2.54

13.84

8.4

9.8

24.04

24.52

mmol/l

0.54

348

Benign neoplasm of urinary organs

131

643

2.13

13.80

8.1

7.9

23.93

24.21

mmol/l

0.50

126

588

Acute bronchiolitis

135

595

2.09

13.79

10.7

13.1

24.28

23.98

mmol/l

0.42

126

570

Other extrapyramidal and movement disorders in other diseases

597

4308

1.41

13.74

7.3

8.9

24.54

24.33

mmol/l

0.80

545

4020

Childhood asthma (age<16), excluding more controls

204

903

1.81

13.66

13.1

8.3

23.71

23.53

mmol/l

0.35

195

860

Benign lipomatous neoplasm

656

4804

1.38

13.64

8.4

9.4

24.30

24.42

mmol/l

0.47

612

4413

Carcinoma in situ of skin of trunk

433

2.40

13.59

8.1

7.4

24.54

24.26

mmol/l

0.35

396

Retinal vascular occlusion

357

2346

1.56

13.57

9.4

8.1

24.08

24.37

mmol/l

0.75

323

2163

Malignant neoplasm of rectum

298

1882

1.64

13.56

9.0

8.9

24.21

24.27

mmol/l

0.13

284

1749

Otitis externa

552

3936

1.43

13.56

8.5

9.5

24.40

24.21

mmol/l

0.70

508

3682

Discitis, unspecified

249

2.92

13.48

11.7

10.4

24.59

24.64

mmol/l

0.05

236

Eosinophilic disease (BM)

136

3.59

13.45

14.5

8.7

24.56

23.43

mmol/l

1.32

129

Psoriasis

753

5650

1.35

13.45

9.6

9.7

24.51

24.27

mmol/l

1.31

686

5300

Carcinoma in situ of skin of upper limb, including shoulder

313

2.67

13.43

11.5

7.1

24.51

24.33

mmol/l

0.18

286

Disorders of speech understanding and production

109

493

2.25

13.39

14.1

10.4

24.21

24.11

mmol/l

0.13

103

463

Dislocation, sprain and strain of joint and ligaments of hip

116

552

2.21

13.36

9.0

9.1

25.02

24.51

mmol/l

1.02

111

520

Vitamin deficiency

138

700

2.05

13.27

13.2

9.9

24.40

24.25

mmol/l

0.17

132

658

Vitamin deficiency, wide

138

700

2.05

13.27

13.2

9.9

24.40

24.25

mmol/l

0.17

132

658

Medical abortion

1377

6000

1.26

13.24

7.7

8.4

24.33

24.45

mmol/l

0.71

1293

5606

Specific development disorders of speech and language

142

697

2.02

13.24

11.1

12.5

24.19

24.13

mmol/l

0.09

135

658

Retinal vascular disorders

361

2391

1.55

13.23

9.4

8.1

24.09

24.36

mmol/l

0.69

326

2201

Diseases of spleen

258

2.84

13.13

8.5

10.0

24.32

24.47

mmol/l

0.13

242

Oral leukoplakia and related diseases

177

981

1.88

13.12

8.7

9.9

24.65

24.40

mmol/l

0.53

166

921

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

220

1295

1.75

13.09

9.1

8.0

24.29

24.35

mmol/l

0.10

214

1175

Mucosal proctocolitis

316

2033

1.59

13.06

10.7

10.5

23.70

24.21

mmol/l

2.17

299

1918

Small fibre neuropathy

435

2.37

13.05

11.5

10.6

23.95

24.52

mmol/l

0.76

411

Fall involving bed

105

487

2.28

12.99

8.6

8.5

25.23

24.54

mmol/l

1.01

450

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

359

2380

1.54

12.97

8.6

9.9

24.46

24.41

mmol/l

0.09

335

2184

Benign neoplasm: Small intestine

135

689

2.06

12.95

7.5

9.6

24.39

24.40

mmol/l

0.01

125

642

Trigeminal neuralgia

165

896

1.91

12.94

6.5

10.0

24.31

24.42

mmol/l

0.19

153

842

Childhood asthma (age<16)

204

919

1.78

12.93

13.1

9.1

23.71

23.54

mmol/l

0.33

195

877

Benign neoplasm: Duodenum

355

2.52

12.91

7.7

24.27

24.41

mmol/l

0.17

324

Infection due to other mycobacteria

221

2.97

12.84

6.4

9.2

24.97

24.83

mmol/l

0.10

200

Disorders of ocular muscles, binocular movement, accommodation and refraction

1089

8553

1.27

12.79

11.3

9.7

24.31

24.23

mmol/l

0.35

1012

8034

Hyperaldosteronism

445

2.34

12.79

11.1

11.4

24.55

24.58

mmol/l

0.02

423

Excessive attrition of teeth

866

3571

1.33

12.78

8.6

9.1

24.11

24.32

mmol/l

1.11

810

3345

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

5.99

12.75

18.3

7.0

24.94

25.13

mmol/l

0.11

Other infective otitis externa

172

952

1.87

12.72

10.2

24.20

24.27

mmol/l

0.11

161

899

Liposarcoma, excluding all cancers (controls excluding all cancers)

143

3.56

12.71

10.5

7.8

24.19

24.81

mmol/l

0.64

129

Bronchitis, not specified as acute or chronic

227

1357

1.71

12.70

7.8

10.4

24.65

24.08

mmol/l

1.88

204

1266

Other specified/unspecified systemic involvement of connective tissue

162

881

1.90

12.66

9.6

9.2

24.10

24.39

mmol/l

0.62

148

832

Other obstructive and reflux uropathy

117

568

2.13

12.65

7.5

9.2

23.39

24.41

mmol/l

2.57

110

530

Carcinoma in situ of skin

242

1481

1.69

12.60

6.9

7.9

24.33

24.40

mmol/l

0.13

227

1376

Other and unspecified injuries of lower leg

176

981

1.84

12.60

7.7

10.4

24.56

24.29

mmol/l

0.59

167

931

Gout due to impairment of renal function

176

3.31

12.59

6.2

10.5

22.99

24.43

mmol/l

1.73

166

Superficial injury of ankle and foot

262

1627

1.64

12.56

9.3

10.7

24.11

24.19

mmol/l

0.15

249

1536

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

196

1129

1.79

12.55

7.8

8.7

24.32

24.41

mmol/l

0.15

174

1030

Other disorders of optic [2nd] nerve and visual pathways

177

995

1.84

12.45

12.4

10.8

24.14

24.36

mmol/l

0.41

168

940

Mixed hyperlipidaemia

125

628

2.08

12.44

15.7

9.2

23.91

24.43

mmol/l

0.87

115

589

Benign neoplasm: Spinal meninges

145

3.50

12.43

5.0

7.7

23.93

24.79

mmol/l

1.47

135

Fibroblastic disorders

664

4953

1.36

12.42

9.9

9.3

24.26

24.29

mmol/l

0.09

620

4604

Other condition

344

2283

1.54

12.39

9.7

10.0

24.17

24.31

mmol/l

0.37

329

2147

Follicular cysts of skin and subcutaneous tissue

478

3382

1.44

12.38

9.0

9.7

24.25

24.23

mmol/l

0.03

446

3168

Dentofacial anomalies [including malocclusion]

573

4124

1.39

12.36

11.4

9.5

24.28

24.30

mmol/l

0.04

530

3880

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

138

718

1.99

12.35

5.5

7.6

24.73

24.28

mmol/l

1.08

132

630

Achalasia of cardia

254

2.78

12.35

11.4

9.6

24.80

24.70

mmol/l

0.08

240

Other neurotic disorders

148

789

1.95

12.35

7.4

10.9

24.35

24.40

mmol/l

0.07

138

739

Drug-induced cataract

357

2.47

12.30

8.4

11.1

24.21

24.50

mmol/l

0.34

337

Diabetic retinopathy

1072

5358

1.29

12.27

12.2

10.7

23.78

24.13

mmol/l

2.23

977

4916

Combinations of oral blood glucose lowering drugs

792

6074

1.32

12.25

12.6

9.2

24.05

24.40

mmol/l

2.00

720

5717

Atopic dermatitis

1238

8511

1.25

12.23

9.2

10.2

24.35

24.22

mmol/l

0.74

1171

8043

Cerebral cysts

147

783

1.94

12.23

11.1

10.9

23.90

24.41

mmol/l

1.11

137

742

Monoamine oxidase A inhibitors

311

2027

1.57

12.20

9.0

9.5

24.47

24.32

mmol/l

0.36

285

1913

Panniculitis affecting regions of neck and back

109

526

2.15

12.04

9.8

11.7

24.57

24.30

mmol/l

0.41

101

502

Gonarthrosis,primary

2648

14372

1.17

11.97

8.5

9.5

24.40

24.33

mmol/l

0.51

2443

13384

Benign neoplasm: Descending colon

212

1272

1.73

11.97

7.2

9.4

23.98

24.39

mmol/l

1.10

196

1191

Benign neoplasm of middle ear and respiratory system

233

1430

1.68

11.94

9.7

10.0

24.75

24.31

mmol/l

1.49

221

1336

Chronic tubulo-interstitial nephritis

107

515

2.16

11.89

8.5

23.08

24.54

mmol/l

3.48

476

Leiomyoma of uterus

873

3782

1.31

11.88

8.3

8.7

24.42

24.52

mmol/l

0.45

817

3488

Benign neoplasm: Skin of eyelid, including canthus

349

2344

1.52

11.87

7.6

8.6

24.30

24.51

mmol/l

0.68

324

2151

Oral leukoplakia and related diseases, including avohilmo

246

1533

1.65

11.84

9.0

9.6

24.49

24.35

mmol/l

0.28

233

1432

Drug-induced osteoporosis

176

3.17

11.84

14.0

7.9

23.72

24.63

mmol/l

0.67

165

Procreative management

690

4375

1.34

11.84

12.7

11.6

24.23

24.28

mmol/l

0.20

661

4120

Urolithiasis

927

7289

1.29

11.81

8.7

9.4

24.09

24.22

mmol/l

0.61

870

6769

Calculus of kidney and ureter

855

6656

1.30

11.81

8.8

9.5

24.08

24.22

mmol/l

0.63

806

6179

Internal derangement of knee

996

7870

1.28

11.78

9.4

10.4

24.35

24.33

mmol/l

0.08

927

7378

Enthesopathies of lower limb, excluding foot

546

3982

1.39

11.77

7.5

10.0

24.43

24.22

mmol/l

0.85

510

3758

Other renal tubulo-interstitial diseases

271

2.63

11.74

12.0

8.9

23.99

24.65

mmol/l

0.89

252

Disorders of optic nerve and visual pathways

236

1456

1.66

11.74

10.8

10.0

24.16

24.25

mmol/l

0.18

225

1375

Benign neoplasm: Stomach

273

1748

1.61

11.74

10.6

8.8

24.64

24.35

mmol/l

0.73

251

1634

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

120

3.71

11.72

9.6

6.8

25.18

24.88

mmol/l

0.27

110

Fracture of forearm

1348

10334

1.23

11.72

10.2

9.0

24.35

24.39

mmol/l

0.15

1255

9637

Abnormal findings on diagnostic imaging of other body structures

321

2128

1.54

11.70

10.1

8.6

24.12

24.22

mmol/l

0.22

303

1982

Dental operations, only avohilmo

2204

9594

1.19

11.70

9.0

9.4

24.27

24.29

mmol/l

0.08

2062

8866

Entropion and trichiasis of eyelid

258

1634

1.63

11.66

6.8

8.0

24.47

24.29

mmol/l

0.42

232

1494

Superficial injury of wrist and hand

440

3099

1.44

11.62

10.2

10.4

24.44

24.18

mmol/l

1.07

411

2914

Fibromyalgia

185

1072

1.76

11.58

10.2

8.1

24.55

24.34

mmol/l

0.54

178

1001

Other and unspecified tonsillitis

719

4631

1.33

11.49

12.1

11.6

24.05

24.08

mmol/l

0.11

671

4409

Other specified/unspecified dorsopathies

103

496

2.16

11.48

11.7

10.7

24.62

24.39

mmol/l

0.25

474

Car occupant injured in noncollision transport accident

103

496

2.16

11.47

11.7

12.1

24.57

24.50

mmol/l

0.06

468

N06DA Anticholinesterases

545

5970

0.73

11.45

4.3

7.1

24.30

24.38

mmol/l

0.21

482

5444

Use of anticholinesterases

545

5970

0.73

11.45

4.3

7.1

24.30

24.38

mmol/l

0.21

482

5444

Thyrotoxicosis with toxic multinodular goitre

170

973

1.81

11.33

6.8

7.7

25.28

24.55

mmol/l

2.11

165

906

Mixed connective tissue disease

170

972

1.80

11.30

10.7

9.4

23.95

24.36

mmol/l

1.05

158

916

Acute pharyngitis

320

2116

1.52

11.27

11.7

11.4

23.86

24.06

mmol/l

0.55

306

2015

Sulfasalazine

687

5225

1.33

11.19

9.4

9.2

24.58

24.17

mmol/l

2.88

633

4899

Migraine without aura

334

2245

1.50

11.17

10.7

9.8

24.16

24.12

mmol/l

0.11

314

2116

Pleural plaque

300

1986

1.55

11.17

6.9

8.1

25.10

24.03

mmol/l

5.44

268

1816

Syphilis

398

2.31

11.16

8.4

13.3

24.19

24.55

mmol/l

0.45

379

Type1 diabetes, definitions combined, early onset

136

723

1.91

11.15

15.5

11.6

22.94

24.09

mmol/l

2.58

130

694

Infections with a predominantly sexual mode of transmission

588

4367

1.36

11.14

9.7

9.9

24.06

24.19

mmol/l

0.46

546

4126

Open wound of wrist and hand

1102

8805

1.25

11.11

10.7

10.3

24.34

24.18

mmol/l

0.87

1026

8251

Other specified/unspecified hearing loss

242

1528

1.63

11.08

8.6

8.9

24.37

mmol/l

0.01

215

1418

Extrapyramidal and movement disorders

985

7864

1.27

11.05

6.9

8.7

24.60

24.32

mmol/l

1.84

899

7289

Other and unspecified abdominal hernia

121

628

2.01

11.04

10.8

10.5

24.56

24.36

mmol/l

0.23

113

592

Other disorders of prostate

127

672

1.98

11.03

5.7

10.5

24.22

24.07

mmol/l

0.25

118

627

Other and unspecified glaucoma

205

1246

1.70

10.99

8.9

8.0

24.04

24.44

mmol/l

0.97

190

1151

Amenorrhoea

129

680

1.93

10.97

11.4

8.6

24.06

24.07

mmol/l

0.01

118

640

Other noninfective disorders of lymphatic vessels and lymph nodes

103

506

2.12

10.95

12.8

9.6

24.66

24.40

mmol/l

0.31

481

Implicit parasitic Sepsis

5.09

10.91

16.0

5.3

24.91

24.57

mmol/l

0.19

Sarcoidosis

352

2415

1.49

10.87

14.1

9.7

24.42

24.34

mmol/l

0.17

329

2269

Mixed disorders of conduct and emotions

193

2.84

10.85

14.2

9.0

23.66

23.71

mmol/l

0.04

184

Striking against or struck by other objects

782

6077

1.30

10.83

9.5

10.8

24.47

24.20

mmol/l

1.78

735

5703

Parodontitis, under 40 years, or operation codes

145

796

1.85

10.83

10.0

11.0

23.42

23.81

mmol/l

0.67

135

749

Lichen simplex chronicus and prurigo

179

1053

1.75

10.82

9.6

9.7

24.14

24.28

mmol/l

0.21

169

993

Obsessive-compulsive disorder

119

614

1.98

10.80

12.3

10.2

24.41

24.10

mmol/l

0.60

106

587

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

146

808

1.86

10.79

11.6

9.6

24.63

24.45

mmol/l

0.30

140

750

5-aminosalicylic acid

488

3545

1.39

10.79

11.4

9.8

23.92

24.11

mmol/l

0.74

457

3336

Other other unspecified disorders of the circulatory system

117

606

2.02

10.79

7.9

10.3

24.18

24.50

mmol/l

0.54

110

571

Superficial injury of forearm

224

1394

1.64

10.76

8.0

10.6

24.11

24.24

mmol/l

0.23

214

1318

Carcinoma in situ of rectum

3.88

10.73

12.8

7.2

24.41

24.96

mmol/l

0.40

Congenital malformations of the musculoskeletal system, not elsewhere classified

141

3.23

10.72

8.4

10.0

24.21

24.27

mmol/l

0.05

135

Schizoaffective disorder

181

1069

1.73

10.67

7.9

10.7

25.29

24.25

mmol/l

2.93

159

1016

Isolated proteinuria

439

2.20

10.62

9.3

10.3

23.18

24.43

mmol/l

2.43

416

Benign neoplasm: Tongue

433

2.21

10.61

7.5

9.8

25.03

24.46

mmol/l

1.05

405

Parodontitis, under 40 years

144

794

1.84

10.61

10.1

11.0

23.45

23.81

mmol/l

0.60

134

747

Disorders of lacrimal system

1014

8156

1.26

10.61

7.6

9.0

24.57

24.36

mmol/l

1.31

925

7624

Disorders of the thyroid gland

2601

14789

1.16

10.59

9.5

9.2

24.34

24.27

mmol/l

0.61

2417

13796

Lymphoid leukaemia

148

830

1.84

10.57

10.0

9.0

24.39

24.27

mmol/l

0.21

139

760

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

108

547

2.05

10.54

10.2

9.5

24.66

24.37

mmol/l

0.46

505

Paralytic strabismus

201

1229

1.69

10.53

8.8

9.3

24.43

24.29

mmol/l

0.24

187

1154

Viral agents as the cause of diseases classified to other chapters

293

2.48

10.52

11.6

10.3

24.27

24.42

mmol/l

0.17

282

Type of accident

687

5277

1.32

10.49

8.6

9.4

24.14

24.25

mmol/l

0.38

642

4936

Ocular pain

189

1136

1.71

10.47

9.5

10.1

24.52

24.32

mmol/l

0.35

175

1069

Congenital malformations of great veins

5.94

10.45

18.7

16.0

23.90

24.17

mmol/l

0.16

Intestinal malabsorption

122

646

1.96

10.45

12.4

10.0

23.52

24.35

mmol/l

1.43

114

612

Superficial injury of shoulder and upper arm

279

1841

1.55

10.43

6.2

9.1

24.22

mmol/l

0.00

266

1726

Hypoplasia of dental enamel, including avohilmo

3.83

10.39

27.6

15.7

23.67

23.84

mmol/l

0.12

Encephalitis

416

2.21

10.39

11.6

10.8

24.41

24.43

mmol/l

0.02

393

Vitamin B12 deficiency anaemia

294

1965

1.53

10.38

9.9

8.0

23.80

24.33

mmol/l

2.01

273

1807

Basal cell carcinoma, including avohilmo

1639

10884

1.20

10.35

7.5

8.4

24.22

24.38

mmol/l

1.27

1518

10045

Polyarthrosis

499

3516

1.38

10.31

6.2

8.9

24.67

24.51

mmol/l

0.55

455

3265

Pedestrian injured in transport accident

180

1077

1.72

10.20

11.5

10.0

24.20

24.34

mmol/l

0.26

172

1013

Late syphilis

203

2.82

10.16

8.0

11.0

24.24

24.59

mmol/l

0.30

191

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

5.08

10.13

9.1

6.4

24.78

25.09

mmol/l

0.15

Basal cell carcinoma

1599

10744

1.20

10.13

7.6

8.4

24.23

24.38

mmol/l

1.15

1486

9909

Agranulocytosis

282

1882

1.53

10.05

11.3

9.8

24.77

24.32

mmol/l

1.89

269

1763

Melanocytic naevi of trunk

285

1908

1.52

9.97

9.2

9.7

24.32

24.23

mmol/l

0.17

272

1793

Other degenerative diseases of the nervous system

667

3877

1.32

9.96

6.5

8.4

24.26

24.29

mmol/l

0.08

606

3581

Allergic urticaria

187

1136

1.68

9.94

8.3

10.1

24.16

24.27

mmol/l

0.18

176

1070

Artificial joint re-operation

199

1234

1.67

9.94

8.4

24.41

24.48

mmol/l

0.12

190

1151

Other encephalitis

391

2.22

9.91

12.2

11.0

24.44

24.43

mmol/l

0.00

371

Myocardial infarction, unclassifiable

655

4493

1.32

9.88

9.1

7.8

23.94

24.25

mmol/l

1.40

584

4078

Benign neoplasm: Rectosigmoid junction

128

705

1.90

9.85

7.1

9.9

24.32

24.51

mmol/l

0.30

123

660

Dental pulpitis 3

180

767

1.71

9.83

9.9

12.3

23.25

23.61

mmol/l

0.77

171

738

Seropositive rheumatoid arthritis, strict definition

380

2696

1.44

9.83

10.2

8.9

24.85

24.31

mmol/l

2.91

353

2523

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

620

3829

1.33

9.82

6.3

7.9

24.62

24.66

mmol/l

0.10

576

3518

Single spontaneous delivery

601

4202

0.75

9.73

6.9

8.3

24.36

24.46

mmol/l

0.34

566

3903

therapeutic use

462

2.11

9.71

8.2

10.2

24.57

24.35

mmol/l

0.26

428

Suppurative and unspecified otitis media

738

5109

1.29

9.70

10.8

10.4

24.02

24.15

mmol/l

0.54

683

4803

Benign neoplasm: Parotid gland

219

1396

1.61

9.70

12.2

10.0

24.49

24.38

mmol/l

0.20

203

1312

Other and unspecified intracranial injuries

448

2.12

9.68

6.9

10.2

23.63

24.53

mmol/l

1.22

418

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1563

10431

1.19

9.64

7.5

8.4

24.20

24.38

mmol/l

1.44

1446

9620

Pruritus

257

1698

1.54

9.59

7.7

8.9

24.26

24.30

mmol/l

0.06

242

1594

Dental pulpitis 3, only avohilmo

167

713

1.73

9.58

9.7

12.3

23.22

23.55

mmol/l

0.64

158

687

Other disorders of bone

460

3381

1.38

9.56

10.0

9.6

24.22

24.23

mmol/l

0.02

430

3173

Chronic hepatitis, not elsewhere classified

491

2.06

9.56

10.8

9.8

24.11

24.47

mmol/l

0.52

461

Unspecific neurodegenerative disorder

767

6681

0.78

9.53

4.8

7.4

24.18

24.37

mmol/l

0.73

680

6120

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

165

982

1.72

9.52

10.9

9.3

24.61

24.48

mmol/l

0.22

157

911

Renal tubulo-interstitial disorders in diseases classified elsewhere

142

3.15

9.50

7.4

9.7

22.83

24.63

mmol/l

1.79

135

Retinal detachment with retinal break

357

2525

1.44

9.48

8.6

9.3

24.04

24.32

mmol/l

0.92

334

2350

Myositis

379

2.21

9.44

14.6

10.5

24.30

24.61

mmol/l

0.24

359

Rash and other nonspecific skin eruption

246

1620

1.55

9.36

8.8

9.7

24.02

24.28

mmol/l

0.66

230

1520

Myasthenia gravis

260

2.50

9.35

10.7

9.5

25.34

24.65

mmol/l

1.04

244

Cervicalgia

498

3721

1.36

9.32

7.7

9.2

24.42

24.27

mmol/l

0.51

454

3497

Nonpyogenic thrombosis of intracranial venous system

101

3.52

9.31

13.1

14.3

24.38

24.55

mmol/l

0.14

Complications of other internal prosthetic devices, implants and grafts

108

573

1.96

9.28

9.8

8.7

24.18

24.41

mmol/l

0.27

531

Suggestive for eosinophilic asthma

233

1520

1.57

9.28

9.3

10.2

24.85

24.13

mmol/l

3.13

209

1432

Complications of genitourinary prosthetic devices, implants and grafts

329

2.29

9.28

11.4

8.0

24.10

24.54

mmol/l

0.43

302

Background retinopathy and retinal vascular changes

311

2.34

9.26

9.8

11.1

23.86

24.57

mmol/l

1.15

287

Multiple myeloma and malignant plasma cell neoplasms

144

838

1.79

9.22

7.5

8.9

23.68

24.35

mmol/l

1.15

130

781

Molar incisor enamel hypoplasia, with caries

3.99

9.09

26.4

10.9

23.59

23.49

mmol/l

0.06

Ingrowing nail

134

765

1.80

9.04

7.0

11.3

23.77

24.38

mmol/l

1.23

120

722

Other intracranial haemorrhages

510

2.01

9.00

9.6

23.96

24.50

mmol/l

1.06

466

Assault by other specified means

3.56

8.98

18.9

10.4

24.51

24.59

mmol/l

0.06

Psoriasis vulgaris

476

3561

1.36

8.91

9.6

10.1

24.43

24.29

mmol/l

0.39

432

3358

Adult respiratory distress syndrome

193

2.73

8.91

17.1

11.4

24.69

24.54

mmol/l

0.08

183

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

364

2560

1.42

8.91

8.6

7.1

24.43

24.67

mmol/l

0.66

338

2324

Other specified/unspecified necrotizing vasculopathies

205

2.66

8.88

9.0

10.1

24.55

24.47

mmol/l

0.06

193

Inflammatory bowel disease

756

6010

1.27

8.86

10.9

10.0

23.90

24.24

mmol/l

2.44

699

5635

Parodontitis, operation under 40 years and operation codes

132

751

1.78

8.85

10.4

11.0

23.21

23.78

mmol/l

1.05

122

709

Complications following infusion, transfusion and therapeutic injection

193

2.69

8.84

11.1

8.4

24.72

24.51

mmol/l

0.19

178

1125

8779

1.22

8.84

7.3

7.8

24.27

24.39

mmol/l

0.57

1037

8079

Otitis externa, unspecified

249

1664

1.53

8.84

8.0

10.0

24.31

24.25

mmol/l

0.13

228

1570

Congenital malformations of gallbladder, bile ducts and liver

126

3.18

8.83

15.6

10.5

23.54

24.45

mmol/l

1.02

119

Fissure and fistula of anal and rectal regions

586

4517

1.31

8.81

9.5

9.4

24.25

24.30

mmol/l

0.17

541

4207

Primary biliary cholangitis (PBC)

298

2.33

8.80

17.5

7.3

23.74

24.32

mmol/l

0.67

283

Benign neoplasm: salivary glands, exclude unknown (D119)

235

1557

1.55

8.79

11.9

9.8

24.46

24.33

mmol/l

0.25

218

1464

Polymyalgia rheumatica

352

2521

1.43

8.75

8.2

7.8

24.74

24.40

mmol/l

1.17

320

2336

Cardiac murmurs and other cardiac sounds

183

1128

1.63

8.74

10.5

10.0

23.97

24.13

mmol/l

0.26

173

1072

Other and unspecified psoriasis

177

1102

1.65

8.70

13.0

10.6

24.49

24.30

mmol/l

0.33

158

1043

Disorders of synovium and tendon

1298

9824

1.20

8.67

8.9

9.9

24.32

24.34

mmol/l

0.10

1203

9209

Macular pucker

408

3001

1.39

8.67

8.1

8.5

24.26

24.40

mmol/l

0.37

377

2792

Benign neoplasm: Duodenum

421

2.10

8.66

7.7

10.4

24.27

24.59

mmol/l

0.50

396

Papulosquamous disorders

992

8151

1.23

8.61

9.8

9.3

24.46

24.29

mmol/l

0.99

898

7638

Nonsuppurative otitis media

449

2878

1.36

8.60

12.3

10.2

24.07

24.08

mmol/l

0.01

421

2709

Parodontitis, under 40 years and operation codes

131

751

1.77

8.57

10.5

11.0

23.24

23.78

mmol/l

0.98

121

709

Hypothyroidism, other/unspecified

2364

13699

1.15

8.57

9.4

9.1

24.38

24.27

mmol/l

0.94

2184

12778

Amyloidosis

289

2.33

8.57

7.7

9.0

24.02

24.65

mmol/l

0.83

267

Herpesviral [herpes simplex] infections

265

1806

1.49

8.55

9.7

9.3

24.11

24.33

mmol/l

0.60

243

1692

Other hammer toe(s) (acquired)

435

3026

1.37

8.55

7.5

8.6

24.53

mmol/l

0.01

406

2816

Otalgia

187

1183

1.62

8.55

8.0

9.5

24.01

24.35

mmol/l

0.79

175

1119

Other shoulder lesions

221

1451

1.55

8.55

7.6

10.1

24.34

24.36

mmol/l

0.03

201

1365

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

271

1856

1.48

8.50

8.1

9.7

24.42

24.36

mmol/l

0.12

250

1709

Delivery

620

4211

0.77

8.49

7.0

8.3

24.31

24.45

mmol/l

0.57

586

3912

Other strabismus

469

3515

1.35

8.45

12.6

10.2

24.41

24.22

mmol/l

0.67

434

3308

Systemic sclerosis (FG)

303

2.27

8.44

15.4

9.4

24.10

24.15

mmol/l

0.04

292

Other disorders of gingiva or/and edentulous alveolar ridge

131

760

1.78

8.42

11.4

10.5

23.67

24.40

mmol/l

1.68

121

711

Other retinal artery occlusion

412

2.10

8.42

8.7

9.9

24.27

24.53

mmol/l

0.25

381

Hypothermia

279

2.35

8.41

8.8

10.9

23.84

24.49

mmol/l

0.75

258

Benign neoplasm: Other and unspecified parts of mouth

459

2.01

8.35

8.1

24.53

24.55

mmol/l

0.02

425

Dermatophytosis

341

2449

1.42

8.35

7.3

9.7

24.22

24.24

mmol/l

0.05

304

2296

Other Crohn's disease

158

965

1.67

8.32

11.6

10.9

23.39

24.33

mmol/l

3.03

150

916

Erectile dysfunction

258

1768

1.50

8.31

19.8

9.7

23.94

24.13

mmol/l

0.48

242

1648

Single delivery by forceps and vacuum extractor

1100

0.54

8.30

9.3

11.1

23.87

24.02

mmol/l

0.23

1035

Rheumatoid arthritis, including avohilmo

951

7813

1.23

8.29

8.5

8.7

24.63

24.37

mmol/l

1.75

882

7270

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

142

2.96

8.27

7.2

8.9

23.60

25.04

mmol/l

2.67

130

Unspecified visual impairment (binocular)

200

2.60

8.25

13.5

12.7

24.00

24.47

mmol/l

0.45

185

Family history of malignant neoplasm

206

1343

1.56

8.20

9.5

8.3

24.58

24.41

mmol/l

0.50

201

1268

Other benign neoplasms of connective and other soft tissue

206

1345

1.56

8.17

8.9

9.6

24.05

24.33

mmol/l

0.55

190

1239

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

498

1.96

8.17

7.6

7.7

23.08

24.34

mmol/l

3.77

446

Spondyloarthritis

439

3289

1.35

8.13

8.3

9.2

24.33

24.24

mmol/l

0.20

401

3065

Complications of labour and delivery

878

6013

0.81

8.12

8.2

9.1

24.27

24.46

mmol/l

0.92

827

5649

Diffuse large B-cell lymphoma, helper endpoint

113

636

1.84

8.11

9.6

8.1

24.11

24.41

mmol/l

0.49

106

582

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

113

636

1.84

8.11

9.6

8.1

24.11

24.41

mmol/l

0.49

106

582

Mouth breathing

1061

8826

1.21

8.08

8.8

10.6

24.48

24.24

mmol/l

1.91

996

8287

Marfan's syndrome

4.15

8.07

23.0

7.3

24.00

24.22

mmol/l

0.13

Polycystic ovarian syndrome, consortium definition

1441

7383

1.18

8.04

8.5

8.3

24.50

24.42

mmol/l

0.44

1327

6916

Maltreatment syndromes

104

570

1.87

8.02

12.9

11.6

23.76

24.14

mmol/l

0.53

542

Ulcerative colitis

583

4550

1.30

8.02

10.6

9.7

23.88

24.19

mmol/l

1.60

536

4271

Carcinoma in situ of other and unspecified sites

531

1.92

8.01

8.9

23.61

24.29

mmol/l

1.88

492

Carcinoma in situ of skin of upper limb, including shoulder

393

2.10

8.00

11.5

8.9

24.51

24.60

mmol/l

0.09

365

Idiopathic thrombocytopenic purpura

425

2.03

7.99

9.6

10.3

23.55

24.39

mmol/l

1.51

401

Benign neoplasm of major salivary glands

258

1778

1.48

7.98

11.1

9.4

24.50

24.34

mmol/l

0.35

239

1664

Special screening examination for other diseases and disorders

195

1265

1.57

7.96

12.4

8.4

24.01

24.26

mmol/l

0.51

185

1200

Other salmonella infections

538

1.90

7.94

9.8

9.9

24.33

24.39

mmol/l

0.06

504

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

107

597

1.85

7.91

8.3

7.8

23.96

24.39

mmol/l

0.57

539

Other and specified injuries of hip and thigh

312

2.22

7.91

6.0

9.4

24.95

24.48

mmol/l

0.63

288

Carcinoma in situ of skin of trunk

535

1.92

7.90

8.1

8.9

24.54

24.50

mmol/l

0.04

495

Other diseases of gallbladder

128

753

1.76

7.90

10.6

8.2

24.48

24.49

mmol/l

0.01

121

696

Use of donepezil

287

3875

0.70

7.90

4.3

6.9

24.42

24.39

mmol/l

0.07

253

3503

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

118

3.13

7.89

11.3

6.9

24.59

24.91

mmol/l

0.31

106

Crohn disease

294

2076

1.44

7.88

11.0

10.0

23.71

24.25

mmol/l

2.32

277

1952

Exposure to smoke, fire and flames

366

2.11

7.87

10.4

11.6

24.60

24.42

mmol/l

0.17

347

Coxarthrosis, primary, with hip surgery

1289

10374

1.19

7.87

7.9

8.6

24.39

24.37

mmol/l

0.07

1199

9588

Autonomic disorders

320

2.19

7.83

8.3

9.4

24.83

24.53

mmol/l

0.30

298

Oesophageal obstruction

105

586

1.86

7.80

13.5

9.8

24.87

24.43

mmol/l

0.62

100

548

Benign neoplasm of urinary organs

131

779

1.74

7.78

8.1

9.4

23.93

24.42

mmol/l

1.17

126

731

Acquired absence of organs, not elsewhere classified

164

2.73

7.78

10.6

8.1

24.02

24.63

mmol/l

0.71

155

Hypothyreosis and Thyroxine purchase for inclusion criteria

2431

14205

1.14

7.77

9.4

9.1

24.38

24.29

mmol/l

0.75

2249

13247

Other/unspecified enthesopathies of lower limb, excluding foot

161

1006

1.63

7.77

6.6

10.0

24.08

24.39

mmol/l

0.56

148

949

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

211

2.47

7.76

8.1

11.0

23.63

24.33

mmol/l

0.90

200

Nail disorders

198

1299

1.56

7.76

9.9

10.8

24.04

24.32

mmol/l

0.55

177

1228

Other and/or unspecified nontoxic goitre

202

1333

1.55

7.72

6.1

8.4

24.61

24.44

mmol/l

0.43

192

1253

D07AA Corticosteroids, weak (group I)

323

2324

1.41

7.69

8.8

10.1

24.34

24.19

mmol/l

0.37

305

2183

Dermatopolymyositis (FG)

189

2.57

7.65

18.4

9.0

24.64

24.40

mmol/l

0.16

181

Metatarsalgia

212

1416

1.52

7.61

8.7

9.4

24.26

24.42

mmol/l

0.33

201

1336

Hypotension due to drugs

215

2.48

7.60

12.6

9.2

25.28

24.55

mmol/l

0.81

200

Inflammatory diseases of female pelvic organs

1188

7541

1.19

7.59

8.8

8.4

24.49

24.43

mmol/l

0.31

1116

7061

Irregular menses

838

5543

1.23

7.59

8.7

8.9

24.28

24.33

mmol/l

0.15

772

5233

Other inflammation of vagina/vulva

356

2.08

7.56

6.5

7.8

23.64

24.22

mmol/l

0.86

335

Contact with sharp object, undetermined intent

285

2.23

7.52

9.3

11.9

23.76

24.50

mmol/l

1.66

274

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Bicarbonate [Moles/volume] standard in Arterial blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS